Effects of altered expression of the sumo conjugating enzyme, UBC9 on mitosis, meiosis and conjugation in Tetrahymena thermophila by Yang, Qianyi
Purdue University
Purdue e-Pubs
Open Access Dissertations Theses and Dissertations
Fall 2014
Effects of altered expression of the sumo
conjugating enzyme, UBC9 on mitosis, meiosis
and conjugation in Tetrahymena thermophila
Qianyi Yang
Purdue University
Follow this and additional works at: https://docs.lib.purdue.edu/open_access_dissertations
Part of the Biochemistry Commons, and the Molecular Biology Commons
This document has been made available through Purdue e-Pubs, a service of the Purdue University Libraries. Please contact epubs@purdue.edu for
additional information.
Recommended Citation
Yang, Qianyi, "Effects of altered expression of the sumo conjugating enzyme, UBC9 on mitosis, meiosis and conjugation in
Tetrahymena thermophila" (2014). Open Access Dissertations. 395.
https://docs.lib.purdue.edu/open_access_dissertations/395
Graduate School Form 








For the degree of   
Is approved by the final examining committee: 
  
 
Approved by Major Professor(s): ____________________________________ 
        ____________________________________ 
 Approved by:
Head of the Graduate Program    Date
Qianyi Yang
              
EFFECTS OF ALTERED EXPRESSION OF THE SUMO CONJUGATING ENZYME, UBC9 ON 








To the best of my knowledge and as understood by the student in the Thesis/Dissertation Agreement, 
Publication Delay, and Certification/Disclaimer (Graduate School Form 32), this thesis/dissertation  
adheres to the  provisions of Purdue University’s “Policy on Integrity in Research” and the use of 
copyrighted material. 
EFFECTS OF ALTERED EXPRESSION OF THE SUMO CONJUGATING ENZYME, 














In Partial Fulfillment of the  
Requirements for the Degree 
of  



















First and foremost, my deepest gratitude to my research advisor Dr. James Forney, who 
introduced me to the wonders of the scientific world. I thank him for his guidance, 
support, patience and for providing me with an excellent atmosphere for conducting 
research. He is such a knowledgeable person and also humble at the same time. Being a 
primary resource for getting my scientific questions answered, he never made me feel my 
questions were stupid. His help was invaluable in the preparation of this dissertation.  
I would also like to thank my committee members: Dr. Scott Briggs, Dr. Mark Hall and 
Dr. Cliff Weil for their guidance, encouragement, insights and useful comments.  
I thank our collaborators, members of the Hall lab, for their expertise in protein 
biochemistry. Special thanks to Dr. Mark Hall and Brendan Powers for their help with the 
affinity purifications and mass spectrometry. 
I also thank present and past members of Forney group, including all the undergraduates 
that I worked with over the years. You made me realize the impact a good mentor can 
make in the lives of their students. And Dr. Kim Kandl, who spent full two semesters in 
our lab on her sabbatical. I thank her for advice on research, as well as her advice on 
future careers. Her enthusiasm for science is contagious and I admire her persistence to 
answer scientific quandaries.  
I would also like to thank people who were not directly involved in my project but helped 
me out in one way or the other, including Dr. Steve Broyles for his generosity in sharing 
equipment, Dr. Christie Eissler and Dr. Paul South for discussions on science, Kelly 
Sullivan, Michael Melesse and Aurélie Chuong who joined Purdue with me and have 
iv 
 
been there for support, Kristi Trimble for taking such good care of graduate students in 
the department, and everyone in the Department of Biochemistry. 
I also thank Dr. Jim Forney’s wife, Mrs. Nanci Forney, for making West Lafayette my 
second home. She took me out for shopping and she taught me how to bake and she made 
my life outside lab entertained. Things that I will miss a lot after I leave Purdue are her 
chocolate brownies, cheesecakes, and chocolate carrot cake which would fuel me for 
days on end. 
I especially thank my parents for their unconditional love, care and support. Without 
them I would not be able to come this far. I know I can always count on my family in 
times of need.  
One of the best decision I have ever made was to marry to Amjad Nasir, my husband and 
my soul-mate. He has been supportive of me at work and at home. I thank him for his 
understanding and encouragement and for being there by my side through the good times 





TABLE OF CONTENTS 
Page 
ACKNOWLEDGEMENTS ............................................................................................... iii 
LIST OF FIGURES  .......................................................................................................... vi 
LIST OF TABLES  .......................................................................................................... viii 
ABSTRACT  ...................................................................................................................... ix 
CHAPTER 1 INTRODUCTION  ........................................................................................1 
CHAPTER 2 DEPLETION OF UBC9 CAUSES DEFECTS IN SOMATIC AND 
GERMLINE NUCLEI IN TETRAHYMENA THERMOPHILA .........................................15 
CHAPTER 3 IDENTIFICATION OF THE TETRAHYMENA THERMOPHILA UBC9P 
INTERACTOME ...............................................................................................................40 







LIST OF FIGURES 
Figure Page 
Figure 1: SUMO conjugation pathway  ...............................................................................2 
Figure 2: Tetrahymena life cycle  ......................................................................................13 
Figure 3: Sequence alignment of Ubc9p from different species .......................................22 
Figure 4: Generation of UBC9 knock-out strain by homologous recombination in 
Tetrahymena  .....................................................................................................................24 
Figure 5: Depletion of UBC9 is vegetative lethal  .............................................................25 
Figure 6: Generation of conditional UBC9 knockout cell lines  ........................................27 
Figure 7: Growth curve of UBC9 depletion strain .............................................................29 
Figure 8: Depletion of Ubc9p causes instability of nuclei .................................................30 
Figure 9: Cells expressing dominant negative Ubc9p have multiple micronuclei ............31 
Figure 10: Depletion of Ubc9p results in hypersensitivity to DNA damaging agents ......33 
Figure 11: Localization of Ubc9p during conjugation .......................................................34 
Figure 12: Depletion of Ubc9p results in reduced paring ..................................................36 
Figure 13: Reduced expression of Ubc9p leads to stall in meiosis ....................................38 
Figure 14: Tetrahymena cells expressing catalytic inactive Ubc9p arrested at 
macronuclear development stage .......................................................................................39 
Figure 15: Schematic drawing of dual tagged UBC9 ........................................................45 
Figure 16: Purification of Ubc9p interacting proteins from vegetative and mated 
Tetrahymena cells ..............................................................................................................46 
Figure 17: Coomassie staining affinity purified fractions .................................................47 
Figure 18: Graphical representation of functional categories of Ubc9p and SUMO 
interacting partners in both vegetative and mated cells .....................................................49 





Figure 20: Graphical representation of biological processes of Ubc9p interacting proteins 
in yeast ...............................................................................................................................51 
Figure 21: Graphical representation of biological processes of SUMO interacting proteins 
in Tetrahymena ..................................................................................................................81 
Figure 22: Overlap between Ubc9p native purification and SUMO native purification 




LIST OF TABLES  
Table Page 
Table 1: Oligonucleotides used in this study  ....................................................................21 
Table 2: Expression of dominant negative Ubc9p reduces conjugation efficiency  ..........39 
Table 3: Ubc9p interacting proteins identified from log phase vegetative cells ...............52 
Table 4: Ubc9p interacting proteins identified from 8-hour conjugating cells  .................58 
Table 5: List of Ubc9p conjugation-specific interacting proteins in Tetrahymena.  .........64 
Table 6: Putative “junk” proteins that appeared in three unrelated Tetrahymena 
purifications. ......................................................................................................................67 
Table 7: Comparison between numbers of proteins identified from vegetative vs 
conjugating Tetrahymena based on biological function  ...................................................77 
Table 8: Numbers of Ubc9 interacting proteins identified from Ubc9p proteomics screens 
between Tetrahymena and yeast  .......................................................................................78 
Table 9: Number of proteins categorized by biological functions from Ubc9p and SUMO 





Yang, Qianyi.  PhD, Purdue University, December 2014. Effects of altered expression of 
the sumo conjugating enzyme, UBC9 on mitosis, meiosis and conjugation in 
Tetrahymena thermophila. Major Professor: James D. Forney  
SUMOylation is a critical posttranslational modification in eukaryotic species. Ubc9p is 
the E2-conjugating enzyme for SUMOylation and consequently it influences multiple 
cellular pathways.  Nuclear proteins are common targets of SUMOylation and regulate 
nuclear events such as transcription, DNA repair and mitosis. The segregation of the 
Tetrahymena thermophila genome into two different nuclear compartments provides an 
unusual context for the analysis of SUMOylation. Each cell contains a transcriptionally 
silent, diploid germ line micronucleus (MIC) that divides by mitosis and a polyploid 
transcriptionally active somatic macronucleus (MAC) that divides by an amitotic 
mechanism. With the long-term goal to exploit these opportunities we initiated studies of 
Ubc9p and therefore indirectly SUMOylation, on the functionally distinct nuclei in T. 
thermophila using genetic analysis combined with proteomics study. We found that 
complete deletion of the UBC9 gene is lethal. Rescue of the lethal phenotype with a 
GFP-UBC9 fusion gene driven by a metallothionein promoter generated a cell line with a 
slow growth phenotype in the absence of CdCl2-dependent expression of GFP-Ubc9p. 
Altered expression of Ubc9p resulted in differential effects in MICs and MACs. MICs 
were lost from cells during vegetative growth but MACs were capable of division. 
Interestingly, cells expressing a catalytically inactive dominant negative Ubc9p (DN-
Ubc9p) accumulated multiple MICs. Ubc9p depleted cells were hypersensitive to DNA 
damaging agents that promote double-strand DNA breaks. Additional studies point to 
critical roles for Ubc9p during the sexual life cycle of Tetrahymena. Crosses between cell 




fewer exconjugant progeny who successfully completed genetic exchange and 
conjugation than from wild-type controls. In contrast, cell lines that were depleted for 
Ubc9p did not form pairs and therefore could not complete any of the subsequent stages 
of conjugation including meiosis and macronuclear development. The results are 
consistent with roles for Ubc9p in mitosis, meiosis and double strand break repair.  A 
proteomics-based approach generated an unbiased spectrum of Ubc9p interacting 
proteins during Tetrahymena vegetative growth and conjugation. We identified 128 high-
confidence Ubc9p interacting proteins during Tetrahymena vegetative growth and 106 
proteins during conjugation, among which 58 are conjugation-specific. Seven proteins 
with homologs in other species have been reported previously as SUMO substrates, or 
Ubc9p interacting proteins. The Ubc9p interactome covers a wide range of cellular 
processes, including chromatin remodeling, cell cycle progression, stress response, gene 
transcription and Tetrahymena macronuclear development, which further support our 
observations from phenotypic analysis. The findings provide evidence for distinct roles 
for SUMOylation in ciliate nuclei and provide opportunities for future studies of 






CHAPTER 1 INTRODUCTION 
SUMOylation 
SUMOylation is a reversible post-translational modification of lysine residues 
that targets a diverse set of proteins and regulates a wide range of pathways including 
mitosis, meiosis, transcription and DNA repair [1-4].  SUMO (Small Ubiquitin-related 
MOdifier) is a small polypeptide (75-89 amino acids) with structural similarity to 
ubiquitin [5]. It attaches via isopeptide bonds to lysine side chains through a series of 
enzymatic steps catalyzed by E1, E2 and E3 complexes that are analogous to but 
independent from those used for ubiquitin addition.  Nevertheless, the functions of those 
two modifications are different. The primary (but not exclusive) function of ubiquitin 
modification is targeting proteins for proteolytic degradation, on the other hand, 
SUMOylation alters the intracellular localization, protein-protein interactions or other 
types of post-translational modifications of the target [1,3]. While most SUMO substrates 
are found in the nucleus, increasing evidence indicates that SUMOylation can regulate 
processes in the cytoplasm, membrane and mitochondria such as Ion channel activity, 
nuclear export/import, mitochondrial fusion [6-8]. SUMOylation has an emerging role as 
a key regulator in gene expression, chromosome stability, cell cycle regulation and DNA 
repair [1-4,9]. 
All eukaryotic SUMO proteins are expressed as precursor proteins that must be 
processed by a C- terminal hydrolase to expose the C-terminal di-glycine of the mature 
protein [10]. The mature SUMO reacts with ATP in the Uba2-Aos1 SUMO activating 




a conserved cysteine on the Uba2 subunit to form an Uba2-SUMO thioester bond [12] 
(Fig. 1). Next, SUMO is transferred from Uba2 to the E2 conjugating enzyme, Ubc9 [13], 
forming a thioester bond between the conserved catalytic site cysteine of UBC9 and 
SUMO C-terminal carboxyl group. Lastly, Ubc9p transfers SUMO to substrates, via an 
isopeptide bond formed between the SUMO C-terminal glycine residue and a lysine side 
chain contained within the substrate. This step is often assisted by a SUMO E3 ligase that 
enhances the transfer of SUMO from Ubc9p to targets. Many SUMOylation sites contain 
the consensus motif ψKXD/E (where ψ is a large hydrophobic residue, K is lysine, X is 
any residue, and D and E are aspartic acid and glutamic acid respectively). These residues 
directly interact with E3 and Ubc9p and therefore it has a critical regulatory role in 
stabilizing interactions between the E2 enzyme and the substrate [14]. However, it should 
be noted that not all ψKXD/E motifs are SUMOylated [3] and SUMO modification can 
also occur at other lysine residues. 
 
Fig. 1: SUMO conjugation pathway. SUMO undergoes processing by SUMO proteases to 
expose a C-terminal Gly-Gly motif that is required for conjugation. The E1 complex, a 
heterodimer of Uba2 and Aos1, catalyzes a thioester bond between the C-terminal of mature 
SUMO and the catalytic cysteine in Uba2 an ATP-dependent manner. Then the SUMO is 
transferred from the E1 to the catalytic cysteine in the E2 enzyme (Ubc9), forming a 
SUMO-E2 thioester intermediate. Finally, SUMO is attached to the amino group of a lysine 
residue with in the substrate protein. This ligation reaction is assisted by an E3 enzyme. The 
SUMO protein can be released from the substrate by members of the SUMO protease (Ulp) 




Substrate specificity of the SUMO pathway relies mostly on the single SUMO E2 
enzyme and a handful of SUMO E3 ligases that have been identified [15-20]. Unlike 
Ubiquitin E2 enzymes, the SUMO E2 enzyme in vitro is able to recognize and conjugate 
SUMO to targets in the absence of E3 ligases [21]. However, SUMO E3 ligases enhance 
the specificity and efficiency of SUMOylation via two proposed mechanisms. First, the 
E3 ligase may orient the E2-SUMO thioester bond in a preferable conformation for 
catalysis without interacting with the substrate, as is the case for RanBP2 [22]. 
Alternately, the E3 enzyme could directly interact with the substrate by forming a 
complex with the E2-SUMO complex. The Siz and PIAS (Protein inhibitor of activated 
STAT) proteins (in humans) are E3 ligases that interact with E2 and SUMO through their 
SP-RING domain and Siz/PIAS C-terminal domains respectively [23,24] indicating that 
specificity is derived from the combination of interactions between E2, E3 and SUMO.  
Substrate recognition can also be regulated by substrate phosphorylation. SUMO 
substrates can be phosphorylated at the site adjacent to a SUMO consensus motif, aptly 
termed phosphorylation-dependent SUMO motifs (PDSMs) (ψKX(D/E)XXSP where P is 
the phosphate moiety on a serine residue). Phosphorylation enhances SUMO conjugation 
both in vitro and in vivo [25,26] because the phosphorylated serine side chain interacts 
with a basic patch on the E2 surface, increasing interactions with E2 enzyme [27]. 
Phosphorylation of the transcription factor myocyte-specific enhancer factor 2A 
(MEF2A) by cyclin-depended kinase 5 (SDK5) within a PDSM enhances its SUMO 
modification, which further inhibits transcription and results in synapse maturation [28]. 
It should be noted that phosphorylation does not always occur within canonical PDSMs. 
Phosphorylation of NF-κB inhibitor α (IκBα) has been reported to inhibit modification by 
SUMO, and this phosphorylation occurs on a serine residue outside the PDSM [29]. 
SUMO E2 enzyme Ubc9 
Ubc9 is the single E2 enzyme in the SUMO pathway. Loss of function studies of 
Ubc9p in different organisms suggest important roles for SUMOylation in cellular 




different species, these studies have revealed that both Ubc9p and the SUMO pathway 
play critical roles in mitosis, meiosis and DNA damage repair.  
UBC9 and mitosis 
Ubc9 in known to regulate several aspects of mitosis including chromosome 
segregation, cell cycle progression, kinetochore assembly and cytokinesis [15,30-32]. 
Some of the first studies demonstrating the requirement of Ubc9p in mitosis were done in 
the budding yeast showing that depletion of Ubc9p prevents the cell cycle progression 
beyond the G2/M boundary [33]. Degradation of B-type cyclins Clb2 and Clb5, which 
are essential for exit from mitosis, requires the Ubc9p protein. In UBC9-depleted cells, 
CLB5 and CLB2 were significantly stabilized [33]. Most likely, this resulted from the 
absence of SUMO-targeted ubiquitin degradation that was not known at the time. In the 
same model system budding yeast, depletion of UBC9 causes cells to arrest with 
undivided nuclei and high levels of securin Pds1 which is an anaphase-promoting 
complex/C (APC/C) substrate, indicating that SUMOylation is also required for proper 
proteolysis mediated by APC/C [34,35]. In contrast, Schizosaccharomyces pombe cells 
lacking the UBC9 homologue Hus5 are viable but appear to arrest at S/G2 phase and 
show defects in chromosome segregation [35].  Similarly, in the fruit fly Drosophila 
melanogaster, one UBC9 mutant, termed semushi, suffers from wide-spread chromosome 
mis-segregation during embryogenesis [36]. In vertebrate Xenopus egg extracts, 
Topoisomerase II (TOP2) is modified by SUMO-2/3 exclusively during mitosis. 
Inhibition of SUMO modification by expression of a dominant-negative Ubc9p increases 
the amount of unmodified topoisomerase II retained on mitotic chromosomes and blocks 
the dissociation of sister chromatids at the metaphase-anaphase transition, indicating the 
importance of SUMO conjugation in chromosome segregation [37]. Conditional 
depletion of Ubc9p in chicken cell lines leads to an increase in cells with multiple or 
fragmented nuclei, indicating defects in cytokinesis [38]. In contrast to depletion of 
Ubc9p in fission yeast and budding yeast, most of the chick Ubc9p depleted cells commit 
apoptosis without arresting at any phase of the cell cycle, suggesting the apoptosis is 
triggered without activating cell cycle check-point mechanisms when chromosome 




lethality in the early post-implantation stage [39]. In culture, homozygous null UBC9 
mutant blastocysts are viable up to 2 days but subsequently die of apoptosis. Two types 
of mitotic chromosome defects were observed in embryonic Ubc9p deletion mutants: 1) a 
significant increase in the size of nearly all metaphase plates; 2) aberrantly segregating 
chromosome in anaphase. In addition, nuclear organization is grossly altered in Ubc9p 
mutant cells, such as disassembled nucleoli and promyelocytic leukemia (PML) nuclear 
bodies [39] 
UBC9 and meiosis 
A few studies have demonstrated the role of UBC9 in meiosis. The first clue of 
SUMOylation in synapsis came from studies in hamster cells lines [40]. Yeast two-hybrid 
screens identified Ubc9p as a protein that interacts with the Cor1 and Syn1 components 
of the synaptonemal complex (SC). The SC is meiotic structure that promotes both 
genetic exchange between chromosome pairs and correct chromosome segregation to 
daughter cells during meiosis [40]. Additional studies showed that Ubc9p localized to 
meiotic chromosomes in S. cerevisiae and mice [41,42], which suggests that Ubc9p is 
associated with and regulates SC structure. A UBC9-GFP fusion led to meiotic defects. A 
diploid homozygous of UBC9-GFP mutant reduced meiotic division by 50% of the wild-
type level and exhibited decreased sporulation [41]. SUMOylation is also important for 
timely synapsis. Synapsis in the same UBC9-GFP mutant was delayed significantly 
relative to that in the wild-type. At late times in the UBC9 mutant, chromosomes did 
eventually synapsed [41].  In mouse male germ cells, the Ubc9p homolog, UBE2I is 
localized to centromeres after SC disassembly [43], implying potential Ubc9p regulation 
in non-SC proteins. The yeast two-hybrid system was used to identify Ubc9 interacting 
protein in the basidiomycete Corprinus cinereus and revealed that Ubc9p interacts with 
the meiosis-specific RecA homolog, Lim15/Dmc1 (CcLim15) [44]. This interaction 
mediates SUMOylation of the C-terminus of CcLim15 during meiosis. 
Immunocytochemistry demonstrates that CcUbc9 and CcLim15 co-localize in the nuclei 
from the leptotene stage to the early pachytene stage during meiotic prophase I. These 
results suggest that SUMOylation is a potential mediator of meiotic recombination via 




inhibition of SUMO-1 or Ubc9p using a specific antibody or their depletion by specific 
siRNA microinjection in germinal vesicle (GV) - stage oocytes decreased the rates of GV 
breakdown and first polar body extrusion, causing defective spindle organization and 
misaligned chromosomes leading to aneuploidy in the mature oocyte [45]. In addition to 
Ubc9, other SUMO pathway components are known to be indispensable for meiosis. For 
example, the SUMO proteases Ulp1, when deleted, exhibits a cell cycle arrest phenotype 
at meiotic prophase [46], indicating that SUMO modification or removal is likely to have 
specific meiotic functions. 
UBC9 and development 
In addition to its functions in mitosis and meiosis, UBC9 RNAi knockdown in 
Caenorhabditis elegans leads to embryonic arrest after gastrulation. Loss of Ubc9p also 
cause pleiotropic defects in larval development in worms that completed embryogenesis 
[47]. Reduction of maternal zygotic UBC9 during an early stage of zebrafish 
development leads to widespread cell death, but inactivation of zygotic Ubc9p 
transcription in the embryo causes defects in development, including brain, eyes and 
cartilage formation [48]. Together these studies indicate that in addition to regulating 
particular cellular processes, Ubc9p regulates developmental programs in multicellular 
eukaryotes.   
UBC9 and DNA repair 
DNA lesions can occur through exogenous and endogenous agents. One of the 
continuous challenges of all organisms is to faithfully replicate their genomes and 
maintain them in an error-free state as they undergo cell division. DNA double-strand 
breaks (DSBs) represent the most destructive chromosomal lesion and may prove 
deleterious if left unrepaired [49,50]. All eukaryotic cells employ sophisticated cellular 
networks, collectively termed the DNA damage response (DDR) to constantly monitor 
genomic integrity. Increasing evidence suggests that the recruitment of these factors to 
the damage site, as well as their turnover is orchestrated by the crosstalk of post-
translational modifications (PTMs) [51], and SUMO is one important player in this 




upon DNA damage SUMO-1 and Ubc9p accumulate at repair foci in a pathway that 
requires SUMO E3 ligases PIAS1 and PIAS4 [53]. Moreover, the recruitment of receptor 
associated protein 80 (RAP80), a key component in DDR pathway, requires PIAS1 and 
PIAS4. PIAS1 also affects the recruitment of RNF168, another component in DDR 
pathway, as well as its formation of polyubiquitylation [54] 
There is increasing evidences for SUMOylation and Ubiquitylation cross-talk in 
DNA damage repair. A novel class of Ubiquitin ligases, termed SUMO-targeted 
Ubiquitin ligases (STUbL), mediates Ubiquitylation of SUMOylated proteins to target 
them for degradation by the proteasome [55-58]. One of the most extensively studied 
STUbLs is RNF4 [57-61]. In 2012, both Hay and Jackson laboratories uncovered RNF4-
mediated SUMO-dependent protein degradation in DDR [62,63]. Cells in which RNF4 
expression has been abolished are hypersensitive to DNA damage that requires 
Homologous Recombination for its repair, meanwhile, mice deficient in RNF4 display an 
accumulation of ionizing radiation-induced DNA damage. RNF4 recruitment to DNA 
damage sites requires its SIMs and RING domain, as well as DNA damage factors such 
as NBS1, MDC1, RNF8, 53BP1 and BRCA1. Without RNF4, these factors were still 
loaded to damage sites but 53BP1, RNF8 and RNF168 showed delayed removal from 
such foci. Cells lack of RNF4 displayed defective recruiting RAD51 on to single-
stranded DNA, which appeared to be a consequence of reduced recruitment of single-
strand-specific DNA-binding protein replication protein A (RPA) and the CtIP [CtBP(C-
terminal-binding protein)-interacting protein] nuclease complex, resulting in inefficient 
reaction [62]. These studies indicate that RNF4 plays an important role in homologous 
recombination in DNA repair. Prior to the discovery of RNF4, two other RING-finger 
proteins in yeast, Slx5p and Slx8p, were identified as members of STUbL family. Both 
proteins are required for cellular survival following replication stress and deletion of 
either gene causes hydroxyurea sensitivity, meiotic defects and a slow growth phenotype 
[64].  
DSBs are repaired primarily by two pathways: homologous recombination (HR) 




NBS1 (MRN) complex that stabilizes DNA ends, promotes the DNA resection, and 
triggers the recruitment of ATM [66]. DNA resection is carried out by CtIP [67]. In S and 
G2 phase, interaction between CtIP and BRCA1 facilitates DNA end processing [67]. 
Many other proteins, such as CDK, ATM, MRN, are also involved in the entire process 
of DSB resection [68,69]. Next, Rad51/Rad52 are loaded to DSBs where RPA binds to 
the ssDNA overhangs. Invasion of a resected end of the DSB into duplex DNA  to form 
D-loop takes place in the Rad51 filament and both RPA and RAD52 help load Rad51 
onto ssDNA to form filament [70]. The newly synthesized fragments ends joined by 
DNA ligases that form double Holliday Junctions (dHJs). It has been demonstrated that 
SUMOylation is involved in HR. SUMOylation of RPA has been detected in yeast and 
mammalian cells [69,71]. SUMOylation of Rad 52 by SUMO E3 ligase Siz2 stabilizes 
Rad52 and reduces the DNA binding and single-strand annealing activities of this protein 
[72,73].  
Apart from repairing DSB damage, homologous recombination also helps restart 
stalled or collapsed replication forks. In this regard, SUMOylated proteins that are 
relevant to this process include members of RECQ helicase family: BLM (Bloom 
syndrome, RecQ helicase) [74], WRN (Werner syndrome, RecQ helicase) in higher 
eukaryotes [75], and Sgs1 in budding yeast [76]. However, it is very likely that not all 
SUMOylated proteins have been identified and how SUMO affects the activities of these 
proteins and subsequently leads to restart of replication forks is still largely unclear.  
DSBs in budding yeast are mostly repaired by HR which is considered as a high-
fidelity way because it essentially involves copying the missing information from its 
homologous chromosome in a diploid cell [77]. On the other hand, NHEJ, which is the 
more common DSB repair pathway in mammalian systems [78,79], involves holding 
broken ends together followed by re-ligation. NHEJ is an imperfect process from the 
standpoint of preserving genetic information because a few nucleotides at each end of the 
broken DNA are missing in most cases in mammals [80] and in many circumstances 




NHEJ starts with the Ku70/80 heterodimer binding to the ends of dsDNA at the 
site of the DSB [82]. DNA-PKcs is recruited to Ku proteins to form the active DNA-PK 
protein ligase [83]. Synapsis forms when two broken ends are held together by two DNA-
PKcs molecules [84,85]. XRCC4/DNA ligase IV complex is recruited to DNA-PKcs to 
carry out processing and aligning DNA ends, as well as the DNA ligation [86]. Multiples 
NHEJ components are known to be SUMOylated. In humans, XRCC4 is SUMOylated 
[87] and XRCC4 mutants that cannot be SUMOylated are hypersensitive to radiation and 
fail to complete V(D)J recombination [87]. Ku70 is also SUMOylated in yeast. Ku70 
SUMOylation deficiency is associated with short telomeres and internal breaks, as well 
as impaired ability to block DNA end resection and suppression of multiple defects 
caused by inefficient resection, which in turns alters levels of NHEJ [88].  
SUMOylation and ribosome 
Several studies showed that SUMOylation is required for pre-ribosomal complex 
formation in yeast and higher eukaryotes. Eukaryotic ribosomes are comprised of a small 
40S subunit and a large 60S subunit, each of which contains distinct ribosomal proteins 
and ribosomal RNA (rRNA). Biogenesis of ribosomes is a tightly regulated process that 
involves a large numbers of non-ribosomal proteins, called trans-acting factors, as well as 
non-coding RNA species [89,90]. Ribosome biogenesis begins in nucleolus, where 47S 
rRNA is transcribed and assembled into large subunit called 90S pre-ribosome complex, 
which will further separate into 40S and 60S pre-ribosomes that mature independently in 
the nucleolus and cytoplasm. In 2006, Panse et al used a proteomic approach to show that 
SUMO targets several trans-acting factors along the 40S and 60S synthesis pathway, 
including Ytm1, Nop7 and Rix 1 [91]. When components of SUMO conjugation or 
deconjugation are inactivated, several defects in ribosome maturation were observed. For 
example, ULP1, which is a SUMO isopeptidase that is homologous to the human SENP 
family, is required for early and late pre-rRNA processing and nuclear export of 60S 
particle [92]. In humans, deletion of human SUMO-specific-isopeptidase SENP3 strongly 
inhibits the nucleolar processing of 32S rRNA to the 28S rRNA and precludes the 




SUMOylation and transcription regulation 
Transcription factors are a prominent class of proteins targeted by SUMOylation. 
A growing number of SUMO substrates are now allowing attempts to dissect mechanism 
of SUMOylation on transcription in detail. Many studies have led to the conclusion that 
SUMO modification of transcription factors have a role in transcriptional repression 
[95,96]. Also the fact that recruitment of Ubc9p to promoter sequences is sufficient to 
repress transcription further supports this idea [97]. The tumor suppressor ING1b is 
SUMOylated at Lysine 193 in human [98]. The SUMO attachment to ING1b regulates its 
binding to the ISG15 and DGCR8 promoters, which regulates ISG15 and DGCR8 
transcription [98]. Forkhead box transcription factor M1 (FoxM1) is SUMOylated in 
mice [99]. FoxM1 is a key regulator of cell-cycle progression and chromosome 
segregation. SUMOylation-deficient FoxM1 mutant is less active compare to wild-type 
FoxM1, indicating that SUMOylation of FoxM1 enhances its transcriptional activity [99]. 
Increased global acetylation was observed in yeast with reduced SUMOylation due to 
down-regulation of UBC9 which is consistent with the role of SUMOylation in repressing 
transcription given the association between acetylation and gene transcription activation 
[100]. Alongside with evidences of SUMO in transcription repression, there are also a 
few reports where SUMO has been shown to activate transcription. For example, 
SUMOylation of p53 results in an increased transactivation of p53, which suggests a 
novel mechanism to regulate p53 activity [101,102]  
UBC9 autoSUMOylation 
SUMOylation of Ubc9p has been observed in mammalian cells in vitro [103-105]. 
SUMOylation of Ubc9p was also observed in yeast in the analysis of global SUMOylated 
proteins [106,107]. Studies by Knipscheer et al have revealed that Ubc9p is 
SUMOylation at Lys-14 in mammalian cells regulates target discrimination [105]. 
SUMOylation of Ubc9p does not seem to affect Ubc9-SUMO thioester bond formation 
but rather alters the capability of Ubc9p to modify particular SUMO substrates. For 
example, SUMOylation of Ubc9p impairs SUMOylation of RanGAP1 and strongly 
activates SUMOylation of the transcriptional regulator Sp100, whereas its activity toward 




Ubc9p in yeast negatively regulates SUMOylation of septins and Ubc9p 
autoSUMOylation is important for maintaining cell morphology [108]. Interestingly, 
Sp100 contains a SUMO interaction motif (SIM), a non-covalent SUMO binding 
mechanism, which is required for the enhanced SUMOylation of Sp100 by Ubc9p 
autoSUMOylation [105]. This suggests that SIM-mediated recruitment of SUMOylated 
Ubc9p to substrates may represent a novel mechanism of substrate specificity. More 
recently, studies by Klug et al have identified Ubc9p SUMOylation as a key regulatory 
step for synaptonemal complex (SC) formation. Yeast containing a Ubc9p mutant that 
could not be SUMOylated showed a significant reduction of SUMO conjugants during 
meiosis and failed to form a synaptonemal complex [109]. This study has revealed a 
mechanism for E2 regulation that orchestrates catalytic and non-catalytic functions of 
Ubc9. 
In addition to the covalent interaction between Ubc9p and SUMO, Ubc9p also 
interacts with SUMO in a non-covalent manner, where SUMO interacts with Ubc9p at its 
N-terminus rather than the Cysteine active site [110]. It has been shown that non-covalent 
Ubc9p-SUMO interaction promotes SUMO chain formation in yeast [111], but other than 
that the role of this interaction is largely obscure.  
Tetrahymena provides advantages in studying SUMOylation 
Tetrahymena thermophila is a ciliated unicellular eukaryote. Like other ciliates 
Tetrahymena displays “nuclear dimorphism”; the germ-line and somatic genomes are 
segregated into separate nuclei called the micronucleus (MIC) and macronucleus (MAC) 
respectively. The diploid micronuclei possess features of typical eukaryotic nuclei; they 
divide by mitosis during vegetative cell division and undergo meiosis during sexual 
reproduction, also known as conjugation. The micronucleus is transcriptionally inert and 
gene transcription is limited to the macronucleus, which is composed of an amplified 
subset (45 copies) of the sequences present in the MIC. Both nuclei replicate their 





Vegetative cell division 
MICs and MACs replicate their DNA at different points in the cell cycle 
[112,113]. In non-dividing cells, the MIC rests in a pocket in the MAC. Division of the 
MIC starts first, followed by amitotic division of the MAC that does not have functional 
centromeres. When mitosis starts, the MIC becomes spindle shape and is still half-
attached to the MAC. Next, the MIC is detached from the MAC and becomes a thin 
thread, which quickly becomes shortened and disappears, leaving the MIC directly 
attached to the cortex on one end and to the MAC on the other end. In the meantime, the 
MAC moves from its central position to a place near the cortex adjacent to the MIC. The 
spindled MIC then gets stretched and divides and returns to the MAC following 
cytokinesis. During MAC amitotic division, the MAC shape becomes irregular for a short 
period of time and then becomes rod shape followed by its fission that coincides with the 
division of the cell.  
MAC chromosomes segregate randomly between the two daughter cells during 
division, as a result, heterozygous progeny will become pure for one allele or the other 
[114]. This phenomenon is called phenotypic assortment and it can be utilized to generate 
a MAC gene knockout in Tetrahymena if the gene is not essential for vegetative growth.  
In Tetrahymena, nuclear dimorphism allows the creation of cells that are 
genetically different in the MIC and MAC [115]. Combined with phenotypic assortment, 
scientists are able to construct genetically useful strains that carry a non-expressed 
mutation in the MIC but express only the non-expressed mutant in MAC, which can be 
either homozygous or heterozygous.  Mutations in essential genes can be maintained as 
heterokaryons, containing the lethal mutation in the MIC and a wild-type MAC. Only 
after mating will the lethal genotype be expressed in the newly formed MAC that is 
generated from the MIC genome.   
Conjugation 
Conjugation is the sexual stage of the Tetrahymena life cycle.  Cells must be 
starved for a period of time in order to be mating reactive. Mating pairs form between 




meiosis and macronuclear development. MIC meiosis starts at ~2h after cells are mixed.  
It elongates to form an unusual crescent shaped MIC that corresponds to meiotic 
prophase, during which chromosome pairing and recombination occurs.  Following the 
crescent stage, the chromosomes condense and standard meiotic divisions occur, giving 
rise to four haploid products, one of which is selected for survival and the other three are 
destroyed.  The selected meiotic product undergoes mitosis to produce two identical 
haploid pronuclei, one of which remains in the cell and the other is transferred to the 
mating partner. The migratory and resident nuclei in each cell fuse producing one diploid 
zygotic MIC in each partner. The zygotic MIC undergoes two rounds of mitosis, 
generating four diploid nuclei, one of which develop into MICs and two become MACs. 
Eventually, the parental MAC condenses and is degraded (Fig. 2).  
 
 
Fig.2: Tetrahymena life cycle. Cells of two different mating types are mixed and pair at 
1.5 hours post-mixing. MIC undergoes meiosis by elongated into a crescent shape, which 
corresponding to meiotic prophase I. MIC then will divide twice, generating four haploid 
nuclei, only one of which is selected and retained. This round of division is terms pre-
zygotic division. The surviving progeny will form a zygotic nuclei with its counterpart 
from its partner. Events involved in this process include chromosome pairing and cross-
over. Two post-zygotic mitosis produce four diploid, two of which develop into new 
MACs and two of which will become new MICs. During this time, massive DNA 
rearrangement occur. After feeding, the first cell division occurs as the cells return to 
vegetative growth. 
 
As the macronuclear anlagen develops, the genome undergoes a massive 
reorganization. The five micronuclear chromosomes are broken down into approximately 
180 macronuclear chromosomes [116].  The single-copy of micronuclear rDNA is 




DNA elements, called internal eliminated sequences (IES) are removed from the genome, 
at the same time the genome in the macronuclear anlagen undergoes several rounds of 
DNA replication without cell division, resulting in a total of approximately 45 copies of 
each MAC chromosome.  
IES elimination is an extensively studied process in Tetrahymena [118,119]. The 
removal of these elements is accompanied by the generation and ligation of DNA DSBs, 
which makes Tetrahymena a wonderful system to study DSB repair. 
IES elimination is an RNA-directed event, which depends on the RNA 
interference pathway. The genome of the micronucleus is bidirectionally transcribed 
early in conjugation. The resulting double-strand RNA is processed by a Dicer-like 
enzyme to 28bp scanRNA (scRNA), which are incorporated into a complex containing an 
argonaute protein Twi1p [120]. The mechanism for scRNA identification of DNA that 
should be eliminated during MAC development is not fully established, but the current 
model has the following features. The parental MAC genome is scanned by the scRNA 
complexes and those complexes containing scRNAs with homology to macronuclear 
sequences are degraded. The remaining complexes that are complementary to MIC-
limited sequences are transported to the developing macronucleus, where they identify 
their homologous DNA sequence and induce formation of specialized heterochromatin 
that is subsequently excised from the germline genome [118,119]. 
The synchronous molecular events of Tetrahymena conjugation including 
meiosis, RNAi scanning, programmed double strand DNA breaks and repair provide a 





CHAPTER 2 DEPLETION OF UBC9 CAUSES DEFECTS IN SOMATIC AND 
GERMLINE NUCLEI IN TETRAHYMENA THERMOPHILA 
Introduction 
Post-translational modification by Small Ubiquitin-related MOdifier (SUMO) is a 
major regulator of protein function. The mechanism of SUMO attachment to substrates 
shares common features with ubiquitin but unlike ubiquitin, which primarily targets 
proteins for proteasome-mediated protein degradation, SUMOylation alters the 
intracellular localization, protein-protein interactions or other types of post-translational 
modifications of the target [2,4]. The importance of SUMOylation as a modification is 
evident in its regulation of progression through the cell cycle, transcription, subnuclear 
architecture, chromosome stability, and nuclear-cytoplasmic transport, mitosis and 
meiosis, and DNA damage repair [1,3,9,53]. SUMO proteins are ubiquitously expressed 
across eukaryotes and proteins required for SUMOylation, such as Uba2p and Ubc9p, are 
highly conserved from yeast to human. Like ubiquitin, SUMO proteins are expressed as 
precursors that need to be proteolytically processed by C-terminal hydrolases to expose a 
C-terminal Gly-Gly motif which participates in the isopeptide bond with lysine residue 
on substrate proteins [12]. The mature SUMO proteins are activated by the heterodimeric 
E1 activating enzyme comprising Aos1p-Uba2p subunits [11] in an ATP-dependent 
reaction. Subsequently, SUMO is transferred from the E1 enzyme active site Cys to a Cys 
residue-linked thioester bond in the E2 enzyme known as Ubc9p [13]. In the last step, 
SUMO is attached to the target protein through a Lys-linked isopeptide bond. In vitro, 
conjugation of SUMO onto substrates can be done directly by Ubc9p; in vivo, E3 ligases 




Ubc9 is the only known SUMO E2 enzyme and therefore a key modulator of 
SUMOylation. Ubc9p was first described as an essential protein for mitosis in fission 
yeast [33]. Studies in several eukaryotes highlight its importance in multiple aspects of 
mitosis, including chromosome integrity and segregation, cell cycle progression, 
kinetochore assembly, and cytokinesis [35,39,122]. In Xenopus egg extracts the 
dissociation of sister chromatids is blocked at the metaphase-anaphase transition when 
SUMOylation of topoisomerase-II is inhibited by a dominant negative Ubc9p [37]. Loss 
of Ubc9p in mice leads to embryonic lethality during the early post-implantation stage 
and results in selective apoptosis of cells of the inner cell mass (ICM) in blastocysts [39]. 
Reduction of Ubc9p activity in zebrafish also shows that Ubc9p is required for G2/M 
transition and progression through mitosis during vertebrate organogenesis [48]. 
Apart from its function in mitosis, UBC9 has also been shown to be involved in 
DNA damage repair and tumorigenesis. SUMOylation has been demonstrated to play 
important roles in the repair of DNA double-strand breaks (DSBs) via Homologous 
Recombination (HR) and Non-Homologous End-Joining (NHEJ). For example, as key 
components of HR machinery, both Rad51 and Rad52 are shown to interact with both 
SUMO1 and Ubc9p [42,73,123]. Depletion of Ubc9p causes significant disruption of 
Rad51 intracellular trafficking, which causes the inhibition of Rad51 nuclear foci induced 
DNA damaging agents [124]. SUMO1/2 and Ubc9p are shown accumulated to the DSBs, 
suggesting their roles in DSBs repair [53].  
  Although investigations of SUMOylation in ciliated protozoa have lagged behind 
other species, they offer a unique platform for studies of nuclear functions of 
SUMOylation. Like other ciliates Tetrahymena thermophila displays “nuclear 
dimorphism” where germ-line and somatic genomes are separated in the micronucleus 
(MIC) and macronucleus (MAC) respectively [125]. The diploid micronuclei possess 
features of typical eukaryotic nuclei; they divide by mitosis during vegetative cell 
division and undergo meiosis during sexual reproduction, also known as conjugation. 
Unlike a typical eukaryotic nucleus, the micronucleus is transcriptionally inert and gene 




(~45 copies) of the sequences present in the MIC. Both nuclei replicate their genomes 
and divide during vegetative growth, but the MAC divides by an amitotic process. 
Previous studies demonstrated that RNAi gene silencing of UBA2 and SUMO in 
Paramecium tetraurelia had little effect on vegetative cells but prevented the excision of 
short regions of DNA called internal eliminated sequences (IESs) during formation of the 
somatic macronucleus [126]. 
We initiated this study to evaluate the contribution of Ubc9p, and therefore indirectly 
SUMOylation, on the functionally distinct nuclei in Tetrahymena. We found that 
complete deletion of UBC9 was lethal, but reduced expression of Ubc9p resulted in 
distinct phenotypes in MICs and MACs. The MICs were lost from cells during vegetative 
growth and MACs were capable of division. However, cells expressing catalytically 
inactive dominant negative Ubc9p (DN-Ubc9) have multiple MICs. Ubc9p depleted cells 
also were hypersensitive to DNA damaging agents that promote double-strand DNA 
breaks. Additional studies point to critical roles for Ubc9p during the sexual life cycle of 
Tetrahymena. Crosses between cell lines that express the dominant negative Ubc9p were 
delayed in meiosis and resulted in fewer true exconjugant progeny than from wild-type 
controls. In contrast, cell lines that were depleted for Ubc9p did not form pairs and 
therefore could not complete any of the subsequent stages of conjugation including 
meiosis. The findings provide evidence for distinct roles for SUMOylation in ciliate 
nuclei and provide opportunities for studies of SUMOylated substrates in a context 
specific for gene expression (MAC) or mitotic and meiotic division (MIC). 
Materials and Methods 
Strains and cell culture. Tetrahymena thermophila cell lines were obtained from the 
Tetrahymena Stock Center (Cornell University, Ithaca, NY). Cells were cultured in 
1×SPP media (2% proteose peptone, 0.1% yeast extract, 0.2% glucose and 0.003% 
FeCl3) at 30 °C according to established procedures [127]. Inbred wild type strains 
B2086 (mpr1-1/mpr1-1 [mpr1; mp-s, II]) and CU428 (mpr1-1/mpr1-1 [MPR1; mp-s, 




B*(VII) that possess defective micronuclei but wild-type macronuclei were used for 
generating UBC9 homozygous germline knockout strains [115,128-130] 
Construction of plasmids. A Tetrahymena UBC9 knockout construct (pUBC9KO) was 
generated by ligating UBC9 flanking sequences into pMNBL, which contains a neomycin 
selectable cassette expressed via the metallothionein 1 (MTT1) promoter from T. 
thermophila [131]. UBC9 upstream sequences (1202 bp; 354,009 to 355,211 of scaffold 
8254664) were amplified by PCR using phusion DNA polymerase (Thermo Fisher 
Scientific), genomic DNA template from wild-type strain B2086 and the knockout 
cassette primers shown in Table 1. The PCR product was cloned into the unique XhoI and 
BglII restriction sites of pMNBL. The corresponding downstream flanking sequences 
(1404 bp; 356,442 to 357846 of scaffold 8254664) were amplified and cloned into the 
unique BamHI and NotI restriction sites. The bacterial neomycin gene, which confers 
paromomycin resistance (pm-r) on transformed cells, is expressed from the CdCl2 (Cd)-
inducible MTT1 promoter.  
A GFP-UBC9 fusion construct was made in a pENTR Gateway plasmid (Life 
Technologies). The 997 bp coding region of the UBC9 gene (TTHERM_00522720) from 
the second codon to the TGA stop, was PCR amplified and cloned into the pENTR-D 
entry vector. The gene cassette in the entry vector was then inserted into a pBS-MTT-
GFP-gtw destination vector (Doug Chalker, Washington University, St. Louis, MO) 
using the LR recombinase in the Gateway cloning system (Life Technologies). 
Successful insertion of GFP-UBC9 fusion gene at the rpl 29 locus confers cycloheximide 
resistance. 
Endogenous C-terminal mCherry fusions were made in the plasmid pmCherryLAP-NEO2 
as described previously [132]. Approximately 1 kb of the 3’ end of UBC9 gene was 
ligated into the KpnI and NotI sites adjacent to the mCherryLAP tag and 1 kb of the 3’ 





The dominant negative UBC9 (pDN-UBC9) construct was generated by inserting an N-
terminal (His)6-FLAG tagged version of UBC9 containing a mutation of the catalytic 
cysteine in the 100th position to a serine residue. The gene was chemically synthesized 
by IDT (Coralville, Iowa) with BsiWI and ApaI restriction sites adjacent to the 5’ and 3’ 
coding regions respectively. The coding region was then inserted into the plasmid pBS-
MTT-YFP-gtw (obtained from Doug Chalker, Washington University, St. Louis) after 
digesting with BsiWI and ApaI. The construct was linearized by HindIII digest and 
transformed into Tetrahymena. This plasmid integrates adjacent to the rpl29 locus and 
confers resistance to cycloheximide (12.5 µg/ml). 
Construction of UBC9 germline knockout. Plasmid pUBC9KO was purified using a 
Qiagen Plasmid Maxi kit (Qiagen) and was linearized with XhoI and NotI digestion. The 
DNA was coated with 0.6 mM gold particles (S550d DNAdelTM Gold carrier particles,  
Seashell Technology, LLC) and introduced into mating B2086 and CU428 populations 
2.5 to 3.5 h post-mixing [133] by biolistic bombardment as described previously [134]. 
Putative transformants with UBC9 disrupted (ΔUBC9) within micronuclei were selected 
by growth in the presence of paromomycin (100 µg/mL) followed by 6-methylpurine (7.5 
µg/mL). The heterozygous (ubc9::neo3/ubc9 [pm-r]) transformants were crossed to star 
strains B*VI and B*VII to generate two homozygous germ line-knockout heterokaryon 
strains, BVI ΔUBC9 (ubc9::neo3/ubc9::neo3 [VI, UBC9+ pm-s]) and BVII ΔUBC9 
(ubc9::neo3/ubc9::neo3 [VII, UBC9+ pm-s]). Star strains contain defective micronuclei 
that do not contribute meiotic products in the cross and therefore result in 
endoduplication of the haploid genome from the heterozygous micronuclear knockout 
strain and generation of a homozygous knockout MIC genome. Star crosses do not 
complete conjugation, they maintain their parental MAC and the progeny of the Star 
parent contains a wild-type MAC with a homozygous knockout MIC.  BVI and BVII 
ΔUBC9 germ line-knockout heterokaryons were crossed to obtain progeny that are 
complete ΔUBC9 homozygous homokaryon strains. These cells were used for phenotypic 
analyses with the initially generated complete micronuclear and macronuclear knockout 
lines described above. Elimination of the UBC9 gene was confirmed by genomic PCR 




Generation of Conditional UBC9 mutant line. The pGFP-UBC9 construct that inserts 
adjacent to the Rpl29 locus was biolistically transformed [133] into mated heterokaryon 
homozygous ΔUBC9 cells at 8 hours post-mixing. Transformed cells were selected with 
12.5 µg/mL cycloheximide and induced with CdCl2 to initiate the expression of the GFP-
UBC9 fusion gene. The knock out heterokaryon parents of the cross have wild-type 
paromomycin sensitive MACs. The cycloheximide resistant, GFP-Ubc9p progeny of the 
cross were tested for paromomycin resistance to demonstrate successful mating and 
generation of the new Ubc9p knock out MAC. 
Isolating DNA, RNA and RT-PCR. Genomic DNA was isolated by Phenol: Chloroform 
extraction followed by isopropanol as described previously [134]. Wild-type 
Tetrahymena thermophila strains B2086 and conditional UBC9 KO strains were used for 
isolation of total RNA using Qiagen RNeasy mini kit (Qiagen) supplemented by a 
QIAshredder for cell homogenization. For RT-PCR, approximately 1 µg of RNA was 
used for the first-strand cDNA synthesis (qScriptTM cDNA supermix, Quanta 
Biosciences) using gene specific primers that amplify wild-type UBC9 
(UBC9WT5’UTRF and UBC9WT5’UTRR shown in Table 1). 
Fluorescence microscopy. Approximately 1 ml of vegetative or conjugating cells were 
concentrated to 106 cells/ml by low speed centrifugation (1,100g), fixed for 30 minutes 
with one volume of 4% paraformaldehyde, washed once in 10 X phosphate-buffered 
saline (PBS, 1.37 M NaCl, 27 mM KCl, 100 mM Na2HPO4 and 18 mM KH2PO4) then 
stained with DAPI at 1 µg/ml (4′, 6′-diamidino-2-phenylindole; 1 μg/ml) for 10 minutes. 
Cells were then examined under fluorescence microscopy (Olympus BX51 TF model 
microscope).  
Growth rate test. Ubc9p conditional mutant strains were first cultured overnight in SPP 
media with 0.1 µg/ml CdCl2 and then transferred to 10 ml SPP medium at a concentration 
of 200 cells/ml in the presence or absence of 1 µg/ml CdCl2. Cell populations were 




Drug sensitivity test. Ubc9p conditional mutant cells and wild-type B2086 cells were 
cultured in SPP medium in the presence of 1.0 ug/ml CdCl2 or no CdCl2 for 24 h and 
treated with 8 mM Methyl MethaneSulfonate (MMS) or 2 mM cisplatin for 2 hours 
respectively and then washed twice with 10 mM Tris-Cl pH7.5. Single cells were isolated 
into drops containing 0.5 µg/ml CdCl2.  After 48 hours, the number of cells in each drop 
was counted. Drops containing fewer than 10 cells were considered non-viable, drops 
with more than 500 cells were considered viable.  
Pairing efficiency test. UBC9 conditional mutants and wild-type were cultured in SPP 
for 16 hours, harvested at 1,100 g, washed twice with 10 mM Tris pH7.5 and starved in 
the presence of 0.05 µg/ml or no CdCl2  for 16-24 hours at 30 degrees. Two different 
mating types were mixed (time 0) and samples of 200 µl were fixed with the addition of 
200 µl 4% paraformaldehyde and counted for pairing efficiency. 100 cells were scored at 
2, 4, 6, and 8 hours post-mixing. Pairing efficiency was calculated by counting the 
number of mating pairs and multiplying by 2 (2 cells per pair) then dividing by the total 
number of cells. 
Table 1. Oligonucleotides used in this study. 
 
Purpose Name Sequence 
   
Knockout cassette UBC9 5’flankF GTCACTCGAGAGGAACCTATGCCGTATTAGATACA 
 UBC9 5’flankR GACTAGATCTGTTTAAATAAATAAGTAAGCAGGTAGCTGC
T 
 UBC9 3’flankF TTAGGGATCCGTAAGAGAATTTGCTGAAACCATG 
 UBC9 3’flankR ATTAGCGGCCGCAGCCTATTCGATCATTATTT 
PCR to confirm knockout lines UBC9KOupstreamF TTGTTATCCTTATGACCAAATTTTCTA 
 UBC9WTupstreamR TGAGCCTAATATTGATAGTCCTGCT 
 MTTpR TTTGCTAACCATAGCCAAAAT 
RT-PCR assay of  conditional lines UBC9WT5’UTRF TCAATTCAGATTCAGCGAAA 
 UBC9WT5’UTRR GCTGATTTCCAATCTTCTTCC 
 UBC9CodingF+start ATCGGGTACCATGTAGCAACAAAATA 
 UBC9CodingR-stop ACTGGAATTCGTCTTTTTTTTTCATGGT 
GFP-UBC9 construct UBC9–startF CACCTAGCAACAAAATAAAGAAGTAAATGAATTAG 
 UBC9+stopR TCAGTCTTTTTTTTTCATGGTTTCAGCAAA 
UBC9-mCherry construct UBC9CodingF+start ATCGGGTACCATGTAGCAACAAAATA 
 UBC9CodingR-stop ACTGGAATTCGTCTTTTTTTTTCATGGT 
 UBC93'FlankF ATCGGCGGCCGCAAAATTCACAAATTAAA 
 UBC93'FlankR TGACGAGCTCAAAGGAGAGAACCAA 
 





UBC9 is an essential gene. We identified a single UBC9 homolog in the Tetrahymena 
genome. Searches of the Tetrahymena Genome Database 
(http://ciliate.org/index.php/home/welcome/) with UBC9 orthologs from S. cerevisiae, S. 
pombe and D.melanogaster revealed the same top Blast hit (TTHERM_00522720). 
Reciprocal searches of the S. pombe and D. melanogaster genomes using the 
Tetrahymena ortholog identified the corresponding UBC9 genes as the top Blast hits. The 
Tetrahymena UBC9 deduced amino acid sequence has approximately 55% identity with 
UBC9 orthologs from yeast and Drosophila.  The deduced amino acid sequence contains 
the conserved catalytic cysteine residue found in other Ubc9p proteins [135] and was 
87% identical across the conserved catalytic domain (Fig. 3).   
 
Figure 3. Sequence alignment of Ubc9 from different species. Dark shading represents 
residues with high identify across all species. Light shading indicates less conserved 
residues. The sequences and accession numbers of Ubc9p are as follows: H Sapiens, 
NM_194261.2; M. musculus, NM_001177610.1; X. laevis, NM_001087289.1; D. rerio, 
BC059506.1; D. melanogaster, AB017607.1; S. cerevisiae, Z74112.1; I. multifiliis, 
XM_004034933.1; P. tetraurelia, XM_001430839.1; T. thermophila, GG662717.1. 
Arrow is pointing to the cysteine active site residue.  
 
Previous studies in budding yeast, nematodes, plants and mice have shown UBC9 is an 
essential gene [13,48,136]. An exception is S. pombe wherein the deletion of hus5 (UBC9 
homolog) causes severe mitotic defects and slow growth but cells can survive [35]. To 




cell lines were constructed. Sequences flanking UBC9 were amplified by PCR and cloned 
into plasmid pMNBL, which contains a neomycin resistance gene (neo3) that is driven by 
the inducible promoter from the metallothionein 1 gene (MTT1) (Fig.4A). The knockout 
construct was introduced into Tetrahymena using standard biolistic transformation 
procedures [134]. The transformed cells were selected for paromomycin resistance and 
then crossed to a test strain to confirm germline integration. Finally the heterozygous 
UBC9 deletion strains were mated with a star strain which contains a defective 
micronucleus. This results in duplication of one of the haploid copies of the MIC genome 
but these cells do not complete conjugation so they maintain a wild-type MAC. The 
resulting cell lines are either wild-type (and investigated further) or homozygous knock 
out heterokaryons with UBC9 deletions in the MIC but wild-type MACs (Fig. 4B). 
Phenotypically these cell lines are paromomycin sensitive (wild-type MAC), but PCR 
amplification generated the expected 481bp product derived from the neo3 insertion in 
the MIC (Fig. 4C). Two homozygous ΔUBC9 heterokaryons cell lines were mated to 
generate complete deletions in both the MIC and MAC in the daughter progeny. 
Individual pairs were isolated and placed in drops with nutrient medium. The majority of 
cells that survived conjugation subsequently died 8-9 cell divisions after mating (Fig. 5). 
The remaining  19 drops contained live cells after 72 hours but these could results from a 
failure to complete conjugation and form a new ΔUBC9 MAC. The drops were replica-
plated to medium containing 6-methypurine in order to identify true exconjugants that 
have successfully completed conjugation by exchanging genetic material and forming a 
new MAC. All 19 drops were sensitive to 6-methylpurine which shows they are not 
UBC9 complete deletions. This result demonstrates that the UBC9 gene is essential for 
vegetative cell viability. Presumably cells survive for several fissions after conjugation 
(with the formation of a new MAC) because Ubc9p from the parental cell is stable and is 
gradually diluted to progeny cells. The results also demonstrate that there is no 







Fig. 4: Generation of UBC9 knock-out strain by homologous recombination in 
Tetrahymena. (A) Sequences flanking UBC9 were PCR amplified and cloned into the 
pMNBL plasmid [131].The plasmid was digested with NotI and XhoI to yield a fragment 
capable of homologous recombination with the complementary sequence on the 
chromosome. The shaded portion of the knockout construct represents the neomycin 3 
cassette [131] that includes the neomycin resistance gene (NeoR) and metallothionein 
promoter (MTTp). PCR primers used to assay integration of the NeoR cassette – one set 
specific for the KO allele and the other specific for the wild-type allele – are shown. (B) 
Schematic of the genetic cross to generate UBC9 knockout heterokaryon strains containing 
homozygous UBC9 deletions in the micronucleus and a wild-type macronucleus. The 
heterozygous ΔUBC9 cell line was crossed to a star strain resulting in a homozygous 
micronuclear genome (see text for additional details). (C) PCR analysis of UBC9 
heterokaryon strains. PCR amplification using the primers shown in panel A was followed by 
separation of the products on an agarose. The homozygous heterokaryon UBC9 KO strains 
generated a knockout product of 480 bp (lanes 5-8) despite a neomycin sensitive (wild-type 
MAC) phenotype. The wild-type strains yielded only the 291 bp wild-type product as 








Fig. 5: Depletion of UBC9 is vegetative lethal. Complete deletion strains of UBC9 
(MIC and MAC) were generated by mating two homozygous germ-line knockout 
heterokaryon strains.  All progeny of UBC9 deletion strains died approximately 8-9 cell 
divisions after conjugation. Progeny of UBC9 heterokaryon knockout and wild-type cells 
were viable and their successful conjugation confirmed by showing paromomycin 
resistance.  
 
Generation of a cell line with conditional Ubc9 expression. The lethal phenotype of 
UBC9 complete deletion strains provided limited opportunities for the molecular analysis 
of Ubc9p function. To circumvent this problem we created a cell line with conditional 
expression of Ubc9p. The strategy involved mating UBC9 homozygous heterokaryons 
strains and then transforming those cells with a green fluorescent protein GFP-UBC9 
fusion gene regulated by the Tetrahymena thermophila metallothionein 1 gene promoter 
(Fig. 6A). The GFP-UBC9 transgene was introduced into the progeny of mated 
homozygous heterokaryon Tetrahymena at 8 hours post-mixing when cells begin to 
generate new MACs. Insertion of transgene into the Rpl29 locus in anlagen confers 
cycloheximide resistance [137]. Transformants were selected with cycloheximide and 
induced with CdCl2 to initiate the expression of the GFP-UBC9 fusion gene. The 
resulting cell lines were GFP positive and paromomycin resistant as expected for the 
progeny of the homozygous heterokaryon parents. As predicted by Ubc9p localization in 
other species, we observed nuclear localization when cells were grown in the presence of 




regulation, conditional mutants were grown in the medium without CdCl2 and in the 
presence of two different concentrations of CdCl2. Cells were fixed with 4% 
paraformaldehyde and examined using fluorescent microscopy. As shown in Figure 6B 
(left panel) no fluorescence signal can be detected in the cells cultured without CdCl2, 
consistent with the low level of MTT promoter activity in the absence of heavy metal.  
On the other hand, an increasing fluorescent signal was observed in the nucleus when the 
cells were cultured in 0.1 mg/ml or 1.0 mg/ml CdCl2 (Fig. 6B, middle and right panel). 
RT-PCR was carried out to confirm the transcript of UBC9. Two sets of primers were 
designed and indicated in schematic drawing (Fig. 6C). The first set was used to detect 
UBC9 transcript at endogenous locus. One primers was in 5’ UTR of endogenous UBC9 
and the other primer was inside UBC9 coding region (Fig. 6C, indicated by arrow heads). 
The second set of primer was used to detect UBC9 coding region, where both primers are 
inside UBC9 (Fig 6C, indicated by arrows). The band corresponding to endogenous 
UBC9 was only observed in wild-type Tetrahymena and was not present in ΔUBC9 
conditional mutants (Fig. 6D, first panel). On the other hand, bands corresponding to 
UBC9 coding regions were detected in both wild-type and conditional mutants (Fig. 6D, 
second panel), which demonstrates that ΔUBC9 conditional mutants express only the 
GFP-UBC9 form and not wild-type UBC9.  We therefore conclude that a conditional 






Fig. 6: Generation of conditional UBC9 knockout cell lines. (A) Schematic drawing of 
the approach used to generate a conditional GFP-UBC9 expressing strain. Heterokaryons 
homozygous UBC9 deletion cells of different mating types were mixed. GFP-UBC9 
construct was biolistically transformed into mated cells at 8 hours post-mixing. (B) The 
expression of GFP-Ubc9p is regulated by CdCl2. The conditional GFP-Ubc9p strains 
were grown in the SPP medium supplemented with different concentrations of CdCl2. 
Cells were fixed, stained with DAPI and viewed by fluorescence microscopy using 10x 
objective. Exposure times were identical for all pictures. (C, D) RT-PCR was used to 
confirm that endogenous UBC9 transcript cannot be detected in conditional mutants. The 
location of the primers used to amplify regions from cDNA are shown (C). One set of 
primer was used to assay UBC9 transcript at its endogenous locus. One primer is located 
in UBC9 5’ UTR and the other one is located inside UBC9 (Showing in arrow head). A 
second set of primer was used to assay UBC9 coding region (showing in arrows). (D) 
Endogenous UBC9 transcript was only detected in wild-type strain but not conditional 
mutants, while UBC9 coding region was present in both wild-type and conditional 
mutants.  
 
Depletion of UBC9 leads to reduced cell growth and nuclear defects. In other species 
Ubc9p has been shown to regulate many aspects of mitosis, including chromosome 
segregation, cell cycle progression [35,39,138]. We made use of our ΔUBC9 conditional 




vegetative growth. To determine whether loss of Ubc9p affects Tetrahymena growth rate,  
equal numbers of cells were inoculated into media with or without 1 µg/ml CdCl2 and 
cells were counted at intervals of 4, 8, 18, 24 and 48 hours.  As shown in Figure 7, the 
ΔUBC9 conditional cells had a slower growth rate than the wild-type strain in the absence 
of CdCl2. However, the same cell lines cultured in CdCl2 exhibited growth rates similar 
to wild-type cells. Depletion of Ubc9p has been shown to cause chromosome mis-
segregation. DAPI staining combined with florescent microscopy revealed that Ubc9p 
depleted cells lost DAPI-detectable micronuclei (Fig. 8A, middle panel). Conditional 
mutants cultured with or without CdCl2, as well as wild-type cells, were isolated after 24 
hours. The number of micronuclei were counted and summarized (Fig. 8B). In the UBC9 
depleted cells, nearly half of the cells contained no DAPI-detectable micronuclei. For 
those cells with MICs, division often involved with unequal partitioning of DNA to 
daughter nuclei (Fig. 8C). This is consistent with defects in separation of sister 
chromatids. Unlike most eukaryotes, Tetrahymena does not require accurate chromosome 
segregation during mitosis because they do not rely on the MIC for gene expression 
during the vegetative life cycle. Cells can be maintained indefinitely with micronuclear 
aneuploidy. Surprisingly, we observed an increase in the number of cells having more 
than two MICs when medium is supplemented with CdCl2. One possible explanation was 
that over expression of Ubc9p has a dominant negative effect due to increased Ubc9p 
activity. In order to test this hypothesis, we generated a cell line expressing a catalytically 
inactive Ubc9p (DN-Ubc9p) due to a point mutation that changes the active site cysteine 
(C100) to a serine.  To reduce the wild-type copy of Ubc9, we also disrupted the wild-
type UBC9 gene by introducing the pUBC9KO plasmid used for the construction of the 
micronuclear knockout into the DN-Ubc9p cell line. These cells should have decreased 
expression of catalytically active Ubc9p, yet rather than lacking micronuclei they contain 






Fig. 7: Growth curve of UBC9 depletion strain. ΔUBC9 conditional mutants and wild-
type cells were inoculated into 10 ml of SPP medium at a concentration of 200 cells/ml in 
either presence or absence of CdCl2. Cell populations were measure by direct cell counts 
at 0, 4, 8, 18, 24 and 48 hours. Cell numbers were plotted by strains in the presence or 
absence of CdCl2. Solid line with solid square represents conditional mutant with CdCl2, 
solid line with empty square represents conditional mutants without CdCl2, dash line with 
solid circle represents wild-type with CdCl2, and dash line with empty circle represents 





Fig. 8: Depletion of Ubc9p causes instability of nuclei. The ΔUBC9 conditional 
mutants were cultured in SPP medium in the presence or absence of 1  CdCl2 for 24 hours 
along with wild-type cells in the absence of CdCl2 (A) Cells sampled after 24 hours of 
culture in the different conditions were fixed with 4% paraformaldehyde and stained with 
DAPI then viewed with a 40x objective under fluorescence. Representative images shows 
that ΔUBC9 conditional cells cultured in the absence of CdCl2 lost micronuclei but 
samples from the same cell lines in the presence of CdCl2 contained at least one 
micronucleus. (B) The numbers of micronuclei were scored and summarized in the pie 
chart. 100 cells from each condition were scored and characterized into three subsets, 
cells with no MIC, cells with 1 MIC and cells with 2 or more MICs. (C) Ubc9p is 
required for proper chromosome segregation. Wild-type or ΔUBC9 conditional mutants 
cultured in 1.0 µg/ml or no CdCl2 were fixed and stained with DAPI. Examples of 
dividing cells (Panel C, a and b) were selected to illustrate nuclear division in each 






Fig. 9: Cells expressing dominant negative Ubc9 have multiple micronuclei. DN-
UBC9-KO cells were grown in 1 x SPP in the presence of 1 µg/ml CdCl2 for 16 hours. 
(A) Samples were fixed and stained with DAPI and viewed with 40x objective. Large 
numbers of cells had multiple micronuclei (Top left panel). (B) For each culture 100 cells 
were scored for the numbers of micronuclei and are summarized in the pie chart (B). 




Depletion of Ubc9p results in hypersensitivity to DNA damaging agents. A role for 
SUMOylation in DNA damage repair, especially in response to double-strand breaks has 
been established in mammalian species and yeast [53,63,76,139,140]. To evaluate 
whether Ubc9p is involved in DNA damage repair in Tetrahymena, we tested the effect 
of DNA-damaging agents MMS and cisplatin on ΔUBC9 conditional mutants. ΔUBC9 
conditional mutants and wild-type cells were cultured separately in SPP medium 
containing 1 µg/ml CdCl2 or no CdCl2.  Cells were treated with 8 mM MMS or 2 mM 
cisplatin for 2 hours then washed twice with 10 mM Tris pH7.5. Single cells were placed 
into drops (approximately 15 µl) of SPP containing 0.5 µg/ml CdCl2. The CdCl2 in the 
post-treatment drops provides conditions that are optimal for growth of conditional cell 
lines and at a disadvantage without cadmium (Fig. 7).  After 48 hours the cells in each 
drop were scored as viable if greater as 500 cells were in a drop and nonviable if there 
were 0-10 cells. No drops had cell numbers between 10 and 500. As shown in Figure 10, 
ΔUbc9 conditional cells cultured in the absence of CdCl2 show only 12% survival in 
MMS compared with 90% survival when cultured with CdCl2. Survival in cisplatin rises 
roughly 15 fold (5% vs 80%) in the presence of cadmium. Wild- type cells show little 
change in sensitivity regardless of the presence or absence of CdCl2 (Fig. 10). This is 








Fig. 10: Depletion of Ubc9p results in hypersensitivity to DNA damaging agents. 
UBC9 conditional mutant strains were grown in 1 x SPP medium in the presence or 
absence of 1 µg/ml CdCl2 for 24 h. Cells were treated with 8 mM MMS or 2 mM 
cisplatin for 2 hours and then washed twice with 10 mM Tris-Cl pH7.5. 80 single cells 
were isolated to drops with growth medium in the presence of 0.5 µg/ml CdCl2 and 
incubated for 48 hours. Drops containing more than 500 cells were scored as viable, and 
drops containing fewer than 10 cells were counted as nonviable. Viability is expressed as 
the percentage of viable drops out of the total. 
 
Ubc9p localizes to developing macronuclei. Tetrahymena conjugation is a dynamic 
process, involving meiosis, selection of one meiotic product, formation of the diploid 
zygotic nucleus, two rounds of post zygotic mitosis and macronuclear development. To 
establish the location of Ubc9p during these nuclear event, we generated Tetrahymena 
cell lines in which a UBC9-mcherry transgene is driven by the endogenous UBC9 
promoter. Cells were prepared for mating by overnight log phase culture then starvation 
in 10 mM Tris pH 7.5 for 16- 24 hours. Cell samples were taken before mixing and at 
various time points after mixing, then fixed and stained with DAPI and observed using a 
fluorescence microscope. Wild-type cells without a mcherry tag were used as controls. A 
faint signal was observed in the macronucleus of starved cells indicating the low 
expression of Ubc9p during starvation (Fig. 11, starvation). During meiosis, the signal 




stage and post-zygotic division stage (Fig 11, T=3-6). At 8 hour post-mixing, the signal 
was accumulated in the developing MAC (Fig. 11, T=8).  The data indicates increased 
expression of Ubc9p during conjugation and the majority of Ubc9p accumulates in the 
developing macronucleus, the site of developmentally regulated genome reorganization.  
 
 
Fig. 11: Localization of Ubc9 during conjugation. Ubc9 was tagged with mCherry on 
the C-terminus at its endogenous locus. Cells were fixed with 4% paraformaldehyde and 
stained with 1 µg/µl DAPI and viewed by a 40x objective under fluorescent microscope. 
The following developmental stage are observed: a. Prophase meiosis I (T=3 hrs); b. 
Zygotic nuclei (T=4 hrs); c. postzygotic division (T=6hrs); d. formation of developing 




Ubc9 is required for pair formation in conjugating Tetrahymena. The localization of 
Ubc9-mcherry to the developing macronucleus suggested a role in conjugation, 
consequently we mated our Ubc9p depleted cell lines to assay for a conjugation defective 
phenotype. ΔUBC9 conditional mutants of different mating types were cultured overnight 
in SPP medium with or without CdCl2 to promote or reduce expression of the GFP-
UBC9 transgene. Cells were washed twice in 10 mM Tris pH7.5 and cultured in the same 
media plus (+Cd) or minus CdCl2 (-Cd). Wild-type cells served as controls and were 
treated with the same conditions. The ΔUBC9 conditional cells from non-CdCl2 treated 
cultures (Ubc9 depleted) were mixed to initiate mating. Separate cultures of CdCl2-
treated Ubc9p conditional lines or wild-type cells were also mixed to initiate cell pairing. 
Cells were evaluated at 2, 4, 6, and 8 hours post-mixing for pair formation. As shown in 
Figure 12, Ubc9p conditional mutant cultures that were not exposed to CdCl2 (Ubc9p-
depleted) were unable to form mating pairs at two hours post-mixing and only formed 10 
% pairs after 8 hours, well past the standard 2 hour pairing period. In contrast, the same 
cell line supplemented with CdCl2 was able to generate 40-60% mating pairs. Wild-type 
cells exhibited pairing efficiencies >90%. Although the conditional cell lines cultures 
with CdCl2 did not pair as well as wild-type cells (59% versus 82% at 8 hours), the 
difference between +CdCl2 and -CdCl2 was much larger (59% versus 4%). We 
consistently observe a slight loss of pairing efficiency when wild-type cells are exposed 
to CdCl2 (see Figure 12) so a large increase upon exposure to CdCl2 is particularly 
significant. In addition to Ubc9p effects on pairing, other experiments in the Forney lab 
show a pairing defect for Uba2 and Smt3 (SUMO) depleted cell lines (A. Nasir and J. 
Forney, manualscript in press). Cells expressing the dominant negative Ubc9p showed 






Fig. 12: Depletion of Ubc9p results in reduced pairing. ΔUBC9 conditional mutants 
were grown and starved in the presence and absence of CdCl2 and mixed. After fixation, 
100 cells were scored for mating efficiency at 2, 4, 6, 8 hours post-mixing. CdCl2- 
depleted cells were unable to from mating pairs. Light blue bar represents wild-type cells 
supplemented with CdCl2, dark blue bar represents wild-type cells without CdCl2; Pink 
bar represents ΔUBC9 conditional mutants with CdCl2 and red bar represents ΔUBC9 
conditional mutants without CdCl2.   
 
Reduced expression of UBC9 results in delayed meiosis. The inability of Ubc9p 
depleted cells to form pairs prevented the analysis of later stages during conjugation. As 
an alternative approach, we decided to mate ΔUBC9 conditional mutants to wild-type 
cells and examine the cells for defects during conjugation. ΔUBC9 conditional mutant 
cells were cultured in the presence and absence of CdCl2 and starved as described in the 
previous experiment. They were mated to wild-type cells that were cultured without 
CdCl2. Paired cells were examined 8 hours post-mixing to check for the progression 
through conjugation. Each pair was placed into one of four categories based on DAPI 
stained nuclei. At 2-3 hours wild-type cells are expected at the crescent micronucleus 
stage (meiotic prophase) followed by prezygotic mitosis, 2nd post-zygotic nuclear 
division and MAC differentiation (expected at 8 hours).  Wild- type cells progressed 




stage as expected (Fig. 13). ΔUBC9 conditional mutants cultured in CdCl2 were slightly 
delayed with 63% of the cells in the second post-zygotic stage and 18% of cells in 
macronuclear differentiation stage. In stark contrast, for conditional mutants in the 
absence of CdCl2 41% of pairs were in meiotic prophase and 28% were in pre-zygotic 
nuclear division stage in their progression through conjugation. Eventually, these cells 
progressed through conjugation which may be attributed to the expression of Ubc9p from 
the wild-type partner.  
Although the ΔUBC9 conditional lines mated to wild-type cells provide some evidence 
for stalling at meiosis, the cell lines may accumulate micronuclear genome defects that 
make it difficult use a genetic assay to test for successful conjugation. We examined 
matings between cells expressing the previously described dominant negative-Ubc9 (DN-
Ubc9) as an alternative approach. When DN-Ubc9p cells were cultured in the presence of 
CdCl2 (inducing expression of DN-Ubc9p) and then mated to each other 32% of mating 
pairs were in the meiotic prophase stage and 51% were at pre- or post-zygotic division 
stage at 8 hours when wild-type cells were in the MAC differentiation stage (data not 
shown). Since these cells were only exposed to CdCl2 immediately before mating the 
progeny were scored for successful conjugation by treating them with 6-methylpurine (6-
MP). The parental strains have the 6-MP resistance gene in the mic but not the MAC. 
Progeny that successfully completed conjugation and form a new MAC are 6-MP 
resistance. . Although there is variation in the frequency of successful conjugation 
between different transformants the cell lines expressing the dominant negative Ubc9p 
display reduced conjugation efficiency relative to the same cell lines without CdCl2. 
(Table 2). 35% of the cells expressing DN-Ubc9p arrested at macronuclear development 
stage (Fig.14). Both sets of genetics crosses, cells with depletion of Ubc9p and cells with 
excess catalytically defective Ubc9p (DN-Ubc9), have defects in conjugation and point 






Figure 13: Reduced expression of Ubc9 leads to stall in meiosis. ΔUBC9 conditional 
mutants were grown and starved in the presence of 1.0 µg/ml CdCl2 or no CdCl2 and 
mixed with wild-type cells to initiate mating, respectively. Samples were fixed with 4% 
paraformaldehyde and stained with DAPI at 8 hours post-mixing. 100 pairs were 
examined under fluorescent microscope and divided into 4 groups based on the 











Figure 14: Tetrahymena cells expressing catalytic inactive Ubc9p arrested at 
macronuclear development stage. DN-Ubc9p cells were grown and starved in the 
presence of 1.0 µg/ml CdCl2 or no CdCl2 and mixed with wild-type cells to initiate 
mating, respectively. Samples were fixed with 4% paraformaldehyde and stained with 
DAPI at 24 hours post-mixing. 100 pairs were examined under fluorescent microscope 





CHAPTER 3 IDENTIFICATION OF THE TETRAHYMENA THERMOPHILA 
UBC9 INTERACTOME 
Introduction 
Ubc9 is the sole SUMO E2 enzyme and therefore interacts with the SUMO E1 complex 
(Uba2p/Aos1p), potential E3s and protein targets of SUMOylation. The majority of the 
Ubc9p interacting proteins have been discovered through yeast two-hybrid screening 
[138,141-144]. Prudden et al revealed that Ubc9p regulates SUMOylation in distinct 
cellular processes through noncovalent interaction [145]. In Tetrahymena, microarray 
expression data shows upregulation in expression levels of SUMO pathway genes during 
conjugation which suggest that SUMOylation may regulate cellular processes during this 
stage of Tetrahymena development. Previous studies demonstrated that RNAi-induced 
silencing of Uba2 and SUMO in Paramecium tetraurelia prevented the excision of IES 
during formation of the somatic macronucleus [126]. This selective effect on DNA 
elimination in the developing macronucleus suggests that SUMOylation is a key 
regulator of this process. Here, I propose that Ubc9p regulates SUMOylation differently 
during vegetative growth and conjugation in Tetrahymena by interacting with different 
proteins. We anticipated major changes in the Ubc9p interacting proteins at different 
stages of conjugation. Previous global analyses of SUMO substrates in S. cerevisiae 
during vegetative growth have produced lists of Ubc9p interacting proteins [146], 
however, there no published studies that document the spectrum of Ubc9p interacting 
proteins between specific developmental settings. 
To broaden our understanding of the function of SUMOylation in the Tetrahymena 
sexual life cycle, we utilized a mass spectrometry-based identification of Ubc9p 




direct Ubc9p interacting proteins during vegetative growth and more than 200 proteins 
during conjugation. Among the identified Ubc9p interacting proteins are players in many 
processes, including proteins involved in cell cycle control, chromosome remodeling, 
ribosome biogenesis, RNA processing, transcription, translation and metabolism.  
Materials and Methods 
Plasmid construction. Tetrahymena thermophila Ubc9p was expressed with an N-
terminal six histidine tag followed by a triple FLAG epitope tag and a short linker 
(GGSG) (Fig. 14).  The Tetrahymena (His)6-(FLAG)3-UBC9 was chemically synthesized 
by IDT (Coralville, Iowa) and inserted into the BsiWI and ApaI sites of pBS-MTT-YFP-
gtw vector (Douglas Chalker, Washington University at St. Louis, MO) to generate 
p(His)6-(FLAG)3-UBC9 plasmid. The plasmid contains the Tetrahymena CdCl2-
inducible MTT1 promoter upstream of the BsiWI insertion site. It also has flanking 
sequences that guide homologous recombination into the rpl29 locus generating 
cycloheximide-resistant Tetrahymena. Expression is induced by the addition of CdCl2.  
Cell transformation and culture conditions. For biolistic transformation the p(His)6-
(FLAG)3-UBC9 plasmid  was digested with HindIII to generate a linear fragment with 
flanking rpl29 sequences. Wild-type B2086 and CU428 Tetrahymena cells were 
transformed as described in Chapter 2 using previously published methods [133]. Cells 
were selected in SPP nutrient medium containing 12.5 μg/ml cycloheximide to identify 
transformants. To induce (His)6-(FLAG)3-UBC9 expression, 0.1 μg/mL CdCl2 was 
supplemented to cell cultures two hours prior to lysis. To generate samples from 
conjugating cells two cultures of different mating types were grown overnight in SPP 
media then washed and starved overnight in 10 mM Tris (pH 7.5). Approximately 500 
mls of starved cells to an Abs540nm of 0.3 from each culture were mixed to induce mating. 
They were treated with 0.05 ug/ml CdCl2 at 6 hours then harvested and lysed at 8 hours 
post-mixing. The samples were processed using the same procedure for tandem affinity 
purification described below. 
Affinity purification. The (His)6-(FLAG)3-UBC9 containing Tetrahymena strain was 




with 10 mM Tris-HCl (pH 7.5) and lysed in 10 ml Native lysis buffer (150 mM NaCI, 50 
mM Tris, 10% Glycerol, 10 mM beta-mercaptoethanol (βME), 1 mM Imidazole, 0.2% 
IGEPAL CA-630 (Sigma, Inc.) pH7.5, with addition of 50 mM NEM and protease 
inhibitors (1 µg/ml E-64, 5 µg/ml antipain, 5 µg/ml leupeptin, 6 µg/ml chymostatin). The 
cell suspension was lysed by sonication (50 pulses at setting 7 with 50% output using 
Misonix XL-2015 sonicator) and clarified by centrifugation at 25,000 rpm in a Beckman 
SW41 Ti rotor for 50 minutes at 4o C. Ten mls of supernatant was incubated with 500 µl 
of Ni-NTA agarose (Qiagen, Valencia, CA) overnight at 4 °C with gentle rotation. Beads 
were washed three times with 10 ml of wash buffer for 15 minutes (150 mM NaCI, 50 
mM Tris, 10 mM Imidazole, pH 7.5) at 4o C. After each wash the beads were collected at 
500 rpm for 3 minutes using J2-MC Backman Coulter High-performance centrifuge. The 
beads were eluted twice with total 10 ml of elution buffer (150 mM NaCI, 50 mM Tris, 
250 mM Imidazole, pH 7.5). The elution fractions were pooled and incubated with 200 µl 
anti-FLAG affinity resin (Genscript, Piscataway, NJ) for 1 hour at 4 °C. Beads were 
washed three times with 10 ml TBS buffer (50 mM Tris-Cl, pH7.5, 150 mM NaCl) and 
collected by centrifugation at 500 rpm for 1 minute. Samples were eluted with 1 ml of 
3xFLAG peptide (Sigma, St. Louis, MO) at a final concentration of 100 µg/ml in TBS. 
The final elution was subjected to Trichloroacetic acid (TCA) precipitation. Briefly, 1 
volume of 100% TCA was added to 4 volumes of protein sample followed by incubation 
at 4 ° C for 10 min. Samples were spun in bench top microcentrifuge (Eppendorf 
centrifuge 5424) at 14K rpm for 5 min to collect pellets, which were further washed twice 
with 200 µl cold acetone. Pellets were air dried and re-suspended in 4 x loading buffer 
(200 mM Tris-Cl pH6.8, 8% SDS, 0.4 % bromophenol blue and 40% glycerol) 
supplemented with 100 mM dithiothreitol (DTT). Samples were incubated for 5 min in 
95 °C heating block before loading onto a polyacrylamide gel.  
Western analysis. Affinity purified protein samples were loaded proportionally onto 
10% polyacrylamide gels for SDS-PAGE analysis. Gels were blotted onto polyvinylidene 
difluoride (PVDF) membranes, which were further blocked in 5% skim milk in PBST 
(0.1% (v/v) Tween 20 in 1x PBS) for 3 hours and incubated with affinity-purified anti-




Blots were washed 3 three, 15 minutes each at room temperature with PBST. Secondary 
horseradish peroxidase-conjugated Goat anti-monse lgG antibody (Jackson 
ImmunoResearch, West Grove, PA) was used at 1: 10,000 dilution followed by washing 
as before and detection by Luminata Crescendo Western HRP substrate (Millipore, 
Darmstadt, Germany) according to manufacture direction.. Blots were typically exposed 
for 30s using ChemiDocTM XRS+ gel imaging system (Bio-Rad, Hercules, California). 
In gel trypsin digestion and protein fractionation. Final purified protein samples were 
separated on 12 % SDS-PAGE and stained with Coomassie Blue R-250. Each lane was 
cut into 5 to 6 small pieces and each piece was transferred into a 1.8 ml low-binding tube 
(Axygen Maxymum Recovery) with 100 µl HPLC-grade H2O. Tubes were incubated at 
room temperature for 10 minutes with gentle shaking. Samples are then washed twice 
with 100 µl freshly made 25 mM ammonium bicarbonate in 50% acetonitrile and 
incubated for 10 minutes with shaking. The final wash was performed with 100% 
acetonitrile for 10 minutes. 100% acetonitrile was removed and followed by trypsin 
digestion at a concentration of 20 µg/ml in 50 mM ammonium bicarbonate overnight at 
37 °C. The tryptic digestion was extracted three time with 50 µl 100% acetonitrile and 
quenched by adding trifluoroacetic acid (TFA) to a concentration of 0.1%, followed by 
C18 column cleanup.  
LC-MS Sample Acquisition and database search. A commercial 5600 TripleTOFTM 
(ABSciex, Concord, Canada) was used for all the experiments. The instrument was 
coupled with an Eksigent NanoLC-2DPlus with nanoFlex cHiPLC (Eksigent, Dublin, 
CA) system. The solvents used were as follows: solvent A: composed of 0.1% (v/v) 
formic acid in water and solvent B:  95% (v/v) acetonitrile with 0.1% (v/v) formic acid. 
The sample acquisitions were performed using a “trap and elute” configuration on the 
nanoFlex system. The trap column (200 m 0.5 mm) and the analytical column (75 m 15 
cm) were packed with 3 m ChromXP C18 medium. Samples were loaded at a flow rate of 
2 nl/min for 10 min and eluted from the analytical column at a flow rate of 300 nl/min in 
a linear gradient of 5% solvent B to 35% solvent B in 90 min. The column was 




solvent B for 10 min. For standard data-dependent analysis experiments, the mass 
spectrometer was operated in a manner where a 250-ms survey scan (TOF-MS) was 
collected, from which the top 50 ions were selected for automated MS/MS in subsequent 
experiments where each MS/MS event consisted of a 50-ms scan. The selection criteria 
for parent ions included intensity, where ions had to be greater than 100 counts/s with a 
charge state between 2 to 4 and were not present on the dynamic exclusion list. Once an 
ion had been fragmented by MS/MS, its mass and isotopes were excluded for a period of 
6 s. Ions were isolated using a quadrupole resolution of 0.7 Da and fragmented in the 
collision cell using collision energy ramped from 15 to 45 eV within the 50-ms 
accumulation time. In the instances where there were less than 20 parent ions that met the 
selection criteria, those ions that did were subjected to longer accumulation times to 
maintain a constant total cycle time. 
The Mascot database search analysis for the reference peptide of the dilution series was 
performed on Mascot v. 2.5. The enzyme selected was trypsin with 2 missed cleavages. A 
search tolerance of 20 ppm was specified for the peptide mass tolerance and 0.2 Da for 
the MS/MS tolerance. The charges of the peptides to search for were set to 2, 3, and 4. 
The search was set on monoisotopic mass and the instrument configuration was set to 
ESI-QUADTOF. No variable or fixed modifications were used. The spectra were 
searched against a reverse database to estimate the false discovery rate. Peptides were 
filtered to an FDR of 1% and proteins were required to have 2 or more peptides identified 
at the 1% FDR level. 
Results 
Isolation of SUMO conjugates during Tetrahymena vegetative growth and 
conjugation. We adopted a scheme that involved a two-step affinity- purification 
strategy using N-terminal tagged Ubc9p with both (His)6 and (FLAG)3 tags (Fig. 15), 
followed by tandem mass spectrometry-based protein identification of trypsin-digested 
proteins. As a control, wild-type Tetrahymena lacking tagged Ubc9p were collected and 
processed under identical conditions. In the first step of the two-step affinity purification, 




preserve non-covalent protein complexes that interact with Ubc9. To achieve a higher 
degree of purification, a second affinity purification step employing anti-FLAG 
antibodies was carried out. Immunoblotting probed with FLAG antibody confirmed the 
tagged Ubc9p signal did not exist in control sample (Fig. 16). Coomassie Blue staining of 
a SDS-polyacrylamide gel with samples purified from vegetative and conjugating 
containing dual-tagged Ubc9p and from untagged negative control, demonstrated very 
few proteins in the control sample (Fig. 17). The Coomassie stained SDS-PAGE gel lanes 
containing the experimental and control samples were each cut into 7 equal-size slices, 
followed by in-gel trypsin digestion and subsequent analysis by LC-MS/MS. Three 




Fig. 15: Schematic drawing of dual tagged UBC9.  UBC9 was N-terminal tagged with 
(His)6, followed by (FLAG)3. Two small linkers were inserted in this construct to 
increase the flexibility. One was Alanine that was inserted between His tag and FLAG 
tag. The other one (GGSG) was inserted between FLAG tag and UBC9 gene. This 
construct is driven by the metallothionein promoter (MTTp) that can be induced by 
CaCl2. Codons were optimized for expression in Tetrahymena usage. Construct was 
chemically synthesized by IDT (Coralville, Iowa) and inserted into the BsiWI and ApaI 
sites of pBS-MTT-YFP-gtw vector (Douglas Chalker, Washington University at St. 









Fig. 16: Purification of Ubc9 interacting proteins from vegetative and mated 
Tetrahymena cells. Samples were collected after each step during purification, for both 
the Ni-NTA and FLAG purifications including whole cell extract (input), flow through 
and elution. Samples were loaded proportionally and resolved by SDS-PAGE (10% gel). 
Top: Fractions from vegetative growth. Lane 1 contains proteins from the tagged Ubc9p 
strain and lane 2 contains protein from is the untagged wild type cell control; lane 3 and 4 
are flow through from Ni-NTA agarose purification of tagged and untagged strains; lane 
5 and 6 are elution from Ni-NTA agarose purification of tagged and untagged strains; 
lane 7 is marker; lane 8 is flow through from anti-FLAG resin of tagged strain; lane 9 and 
10 are elution from anti-FLAG resin purification of tagged and untagged strains. Bottom: 
Fractions from mated samples. Lane 1 contains proteins from the tagged Ubc9p strain 
and lane 2 contains protein from is the untagged wild type cell control; lane 3 is flow 
through from Ni-NTA agarose purification of tagged strains; lane 4 and 5 are elution 
from Ni-NTA agarose purification of tagged and untagged strains; lane 6 is marker; lane 
7 is flow through from anti-FLAG resin of tagged strain; lane 8 and 9 are elution from 






Fig. 17: Coomassie stained gels ofing affinity purified fractions. (His)6-(FLAG)3-
Ubc9 cell lines and untagged control strains were induced with cadmium and then lysed 
under native conditions. The clarified lysates were used for two rounds of affinity 
purification, first with Ni-NTA resin and then anti-FLAG resin. Final elutes were 
separated by SDS-PAGE (12% gel) and stained with Coomassie blue. Left: Purified 
proteins from vegetative cells after elution from the second affinity resin and 
concentration by TCA precipitation.  Lane 1 contains proteins from the tagged Ubc9p 
strain and lane 2 contains protein from is the untagged wild type cell control. Right: 
Proteins from mated cell purifications. Lane 1 and 2 are input of strains with tagged 
protein and untagged; lane 3 and 4 are elution from Ni-NTA agarose purification of 
tagged and untagged strains; lane 5 is marker; lane 6 and 7 are elution from FLAG resin 
puridication of tagged and untagged strains. 
 
LC-MS/MS data were analyzed using mascot to search the database of known 
Tetrahymena proteins sequences. A total of 242 proteins were uniquely found in 
vegetative samples expressing tagged-Ubc9 and 213 were uniquely found in conjugating 
samples. In addition to a large number of novel Ubc9p interacting proteins identified, the 
list includes orthologous of previously identified Ubc9p interacting protein or SUMO 
conjugates in other organisms (e.g. Cdc2, TopI, EEF2, DRH19, multiple aminoacyl-





Evaluation of Ubc9 interacting proteins found through global MS analysis. To our 
surprise, there are large numbers of metabolic proteins were identified in our affinity 
purifications. Many of the same proteins showed up in yeast SUMO purification too 
(personal communication with Dr. Mark Hochstrasser, Yale University). Highly abundant 
proteins complicate the data set as they stick to the epitope tags but are not 
physiologically significant Ubc9p interacting partners. In order to increase our 
confidence in the list of Ubc9p interacting proteins, we compared the proteins on our lists 
to those identified from two other published unrelated Tetrahymena purifications.  In one 
study mitochondria were purified and proteins were identified by mass spectrometry. In 
the other study, the outer pellicle, which is the scaffold for outer membrane structure, was 
purified and proteins identified [148,149]. Proteins that appeared in all three purifications 
works (mitochondria, pellicle and Ubc9) were are subtracted from our lists, which 
resulted in new lists with proteins of higher confidence. Those so-called “junk proteins” 
are summarized in Table 6. After the subtraction of these common proteins, our list 
contained 128 proteins that we have higher confidence direct interact with Ubc9p during 
Tetrahymena vegetative growth (Table 3) and 106 proteins during conjugation (Table 4). 
These two data sets are categorized based on their functions (Fig. 18), including cell 
cycle regulation, RNA processing, gene transcription, chromatin remodeling and stress 
response. The cell cycle proteins that we identified include TopoI, which has been 
previously identified as a SUMO substrate, and CDC2, homolog of which has been 
identified as Ubc9p interacting protein in yeast [146]. Our goal is to identify conjugation-
specific Ubc9p interacting proteins and we anticipate that some of these will be identified 
as SUMO substrates. We compared the Ubc9p interacting protein list from vegetative and 
conjugating cell culture and found 48 proteins that were common which means that there 
were 58 proteins that are specific to conjugation (Fig. 19 and Table 5). These proteins 
include Twi 1 which is an argonaute protein that is required for IES excision during 
macronuclear development [119]. The other example is High Mobility Group B protein 






Fig. 18: Graphical representation of functional categories of Ubc9 and SUMO 
interacting partners in both vegetative and mated cells. Proteins that were identified 
were categorized into different subsets based on their biological functions. The uniprot 
knowledgebase and Tetrahymena Genome Database (TGD) were both used to graphically 
display the biological functions of Ubc9p interacting proteins in (A) vegetative cells, (B) 
mated cells. As expected, a high number of proteins responsible for ribosome biogenesis 
were identified. The largest category of these proteins are involved in metabolic 
processes. However, SUMOylation clearly regulates other key cellular processes such as 
crosstalk with other protein translation modifications, response to cellular stimuli, 






Fig. 19: Overlap between Ubc9 interacting proteins in vegetative growth and 
conjugation. There are 48 proteins that are present in purifications from both vegetative 
growth and mated cells.  
 
In 2013, Dr. Raught’s group identified 97 high-confidence Ubc9p interacting proteins 
from S. cerevisiae using affinity purification followed by mass spectrometry approach 
[146]. Four of these proteins were previously reported as Ubc9p interactors and 37 were 
identified as SUMO conjugates. Again, we compared our Ubc9p list against their data set 
and the majority of them were classified in the same functional category (Fig. 20). This 
included 19% of proteins in metabolism in yeast compared with 27% in Tetrahymena, 
surprisingly high fractions considering SUMOylation is considered primarily a 
modification associated with nuclear proteins. It is possible that Ubc9p (and SUMO) has 





Fig. 20: Graphical representation of biological processes of Ubc9p interacting 
proteins in yeast. 97 high-confidence Ubc9p interacting proteins were reported by 
Sirkumar et al. These proteins are categorized into different subsets based on their major 
functions, including transcription, response to cellular environment, structure 
maintenance, metabolism, cell division, chromatin remodeling, translation, transport, bud 














Table 3: Ubc9 interacting proteins identified from log phase vegetative cells 
Gene Name Standard Name Description Times identified 
TTHERM_00194730   hypothetical protein 1 
TTHERM_00125640 SSA3 (HSP70a paralog) dnaK protein 1 
TTHERM_01080440* SSA4 (HSP70a paralog) dnaK protein 2 
TTHERM_01044390* † HSP71 (Heat Shock Protein ) Putative 70-kDa heat-shock protein (hsp70 2 
TTHERM_00558440*† SSA5 (HSP70a paralog) dnaK protein 2 
TTHERM_01435670 GLC3 (GLC3 Ortholog) Alpha amylase, catalytic domain containing protein 1 
TTHERM_00013700 hypothetical protein   1 
TTHERM_01107480*   hypothetical protein 2 
TTHERM_01287980*   hypothetical protein 3 
TTHERM_00193410 *   serine hydroxymethyltransferase family protein 1 
TTHERM_00318570*†   citrate synthase 1 
TTHERM_00666180*†   conserved hypothetical protein 1 
TTHERM_00535740†   Mitochondrial carrier protein 2 
TTHERM_00535730 MCF2 (Mitochondrial carrier family) Mitochondrial carrier protein 1 
TTHERM_00052470*†   AMP-binding enzyme family protein 2 
TTHERM_00378560*   eukaryotic translation initiation factor 3 subunit 8 1 
TTHERM_00429910*†   cytidyltransferase-related domain containing protein 2 
TTHERM_00015980*   cytidyltransferase-related domain containing protein 1 
TTHERM_00147510†   Coenzyme A transferase family protein 2 
TTHERM_00497940*† RRM34 (RNA recognition motif-containing protein 34)   2 





TTHERM_00658860*   Protein kinase domain containing protein. Sequence similarity to the PKA protein kinase family 1 
TTHERM_01014740*   hypothetical protein 2 
TTHERM_00243730 *†   Glucosamine-6-phosphate isomerase/6-phosphogluconolactonase family protein 2 
TTHERM_00402120 †   Glutathione S-transferase, N-terminal domain containing protein 2 
TTHERM_00663830 XRN3 (5'-3' exoribonuclease 3) XRN 5'-3' exonuclease N-terminus family protein 1 
TTHERM_00205180†   cyclic nucleotide-binding domain containing protein 1 
TTHERM_00551160 *† TDH1 (glyceraldehyde-3-phosphate dehydrogenase 1) Glyceraldehyde-3-phosphate dehydrogenase; metabolic enzyme involved in glycoloysis 1 
TTHERM_00346560*†   Ubiquitin family protein 2 
TTHERM_00085200*†   Ubiquitin family protein 3 
TTHERM_00343440*†   conserved hypothetical protein 1 
TTHERM_00569100   Thioredoxin family protein 2 
TTHERM_00467390  SOR3 (Sortilin 3) BNR/Asp-box repeat family/ VPS10 domain containing protein 1 
TTHERM_00636970 † RPP0 (Ribosomal Protein P0 of the large subunit) 
Homolog of yeast RPP0, human RPLP0, bacteria RPL10; Acidic ribosomal protein P0 
of the large subunit 1 
TTHERM_00056140*† ERS3 (glutaminyl-tRNA synthetase 3) glutaminyl-tRNA synthetase family protein 1 
TTHERM_00773610   enoyl-CoA hydratase/isomerase family protein 2 
TTHERM_00497380 *†   oxidoreductase, zinc-binding dehydrogenase family protein 1 
TTHERM_00614859†   conserved hypothetical protein 1 
TTHERM_00339700*†   hypothetical protein 1 
TTHERM_00024200*   oxidoreductase, short chain dehydrogenase/reductase family protein 1 
TTHERM_00024180   oxidoreductase, short chain dehydrogenase/reductase family protein 1 
TTHERM_00024190*   oxidoreductase, short chain dehydrogenase/reductase family protein 1 





TTHERM_00149340 *† CCT2 (CCT2 Ortholog) TCP-1/cpn60 chaperonin family protein 1 
TTHERM_00522650* DRH19 (DExD/H box RNA helicase 19) DEAD/DEAH box helicase family protein 1 
TTHERM_01048110*†   Glutamate/Leucine/Phenylalanine/Valine dehydrogenase family protein 1 
    60S ribosomal protein L9  1 
TTHERM_00442880    Protein kinase domain containing protein. Sequence similarity to the ULK protein kinase family 1 
TTHERM_01084100 *†   Glutamine synthetase, catalytic domain containing protein 1 
TTHERM_01250050    AMP-binding enzyme family protein 1 
TTHERM_00118600*† PYK1 (PYruvate Kinase) pyruvate kinase; converts phosphoenolpyruvate to pyruvate during glycolysis 1 
TTHERM_00277470*   acetyl-CoA acyltransferases family protein 1 
TTHERM_00836690 *†   Peptidase M16 inactive domain containing protein 2 
TTHERM_00426260*   hypothetical protein 1 
TTHERM_00560000 CRS1 (cysteinyl-tRNA synthetase 1) cysteinyl-tRNA synthetase family protein 1 






Formaldehyde dehydrogenase/S-formylglutathione hydrolase fusion protein; fusion 
protein containing two enzymes known to catalyze sequential steps in the formaldehyde 
detoxification pathway in yeast; this fusion unique to ciliates 
2 
TTHERM_00753340   hypothetical protein 1 
TTHERM_00218410 FRS2 (phenylalanyl-tRNA synthetase 2) phenylalanyl-tRNA synthetase, beta subunit family protein 1 
TTHERM_00035180†   acetoacetate decarboxylase 1 
TTHERM_00534010*   zinc finger protein, putative 2 
TTHERM_00151390   ATP:guanido phosphotransferase, C-terminal catalytic domain containing protein 1 
TTHERM_00813040   hypothetical protein 1 
TTHERM_00670350   hypothetical protein 1 





TTHERM_00954320*   Zinc finger, C2H2 type family protein 1 
TTHERM_00388400†   hypothetical protein 2 
TTHERM_00245120   hypothetical protein 1 
TTHERM_00313119   predicted protein 1 
TTHERM_00133690† FRS1 (phenylalanyl-tRNA synthetase 1) phenylalanyl-tRNA synthetase, alpha subunit family protein 1 
TTHERM_01194660*   translation elongation factor G 1 
TTHERM_00052420   asparagine synthase 1 
TTHERM_00787250   Glutamate/Leucine/Phenylalanine/Valine dehydrogenase family protein 1 
TTHERM_00670340 LRS1 ( leucyl-tRNA synthetase 1) leucyl-tRNA synthetase family protein 1 
TTHERM_00688570   Alanine racemase, N-terminal domain containing protein 1 
TTHERM_00537300*†   ribose-phosphate pyrophosphokinase family protein 1 
TTHERM_00681790*   hypothetical protein 1 
TTHERM_01008630 THC1 (Tetrahymanol cyclase) Metabolic enzyme involved in triterpenoids biosynthesis; catalyzes the formation of tetrahymanol from squalene by a direct cyclization. 1 
TTHERM_00049060   hypothetical protein 1 
TTHERM_00649120   ATP-dependent protease La family protein 1 
TTHERM_00218270*    hypothetical protein 1 
TTHERM_00499390*†   Glycine cleavage system T protein. Sequence similarity to the HisK protein kinase family 2 
TTHERM_00475310†   hypothetical protein 1 
TTHERM_00300370   ABC transporter family protein 1 
TTHERM_00077220   hypothetical protein 1 
TTHERM_00348060*   Acyl-CoA oxidase family protein 1 





TTHERM_00773690†   adenylosuccinate synthetase family protein 1 
TTHERM_00052020   ROK family protein 1 
TTHERM_00028780   hypothetical protein 1 
TTHERM_00023980† RAN1 (RAN GTPase) Putative Ran GTPase; an evolutionarily conserved small GTPase with roles in nuclear transport, mitotic spindle assembly and nuclear envelope assembly 2 
TTHERM_00353480*†   HELP domain containing protein 1 
TTHERM_00196200†   isocitrate dehydrogenase, NADP-dependent family protein 1 
TTHERM_00377250   adenylosuccinate lyase family protein 1 
TTHERM_00069420 MCM5 (DNA replication licensing factor MCM5) Component of the Mcm2-7 complex involved in DNA replication 1 
TTHERM_00197760   hypothetical protein 2 
TTHERM_00558490* PUF2 (Pumilio-family protein 2) Pumilio-family RNA binding repeat containing protein 1 
TTHERM_00035580   preprotein translocase, SecY subunit containing protein 1 
TTHERM_00292170 ERF1 (Eukaryotic Release Factor ) 
Eukaryotic release factor 1; believed to recognize the stop codon of mRNA and 
terminate translation; gene has 4 introns; deduced protein sequence 57% similar to 
human eRF1; domain 1 proposed to be the codon recognition site 
2 
TTHERM_00448660†   hypothetical protein 1 
TTHERM_00659131   conserved hypothetical protein 1 
TTHERM_00077120   hypothetical protein 1 
TTHERM_00312220   nucleotide binding protein 2, putative 1 
TTHERM_00442930*   bZIP transcription factor family protein 1 
TTHERM_00790780   Glycosyl transferase family, helical bundle domain containing protein 1 
TTHERM_00195860†   Thiolase, N-terminal domain containing protein 1 
TTHERM_00526770 MYO13 (MYOsin ) Myosin heavy chain; unclassisfied member of myosin protein family; not a member of proposed myosin Class XX; contains predicted coiled-coil domains 1 
TTHERM_01266070   protein phosphatase 2A regulatory B subunit (B56 family) 1 
TTHERM_00442210 RPN2 (26S proteasome regulatory subunit N2) Proteasome/cyclosome repeat family protein 1 





TTHERM_00382380†   AMP-binding enzyme family protein 1 
TTHERM_01207690   hypothetical protein 1 
TTHERM_01029960 MDH4 (malate dehydrogenase 4) malate dehydrogenase family protein 1 
TTHERM_00697230   cyclic nucleotide-binding domain containing protein 1 
TTHERM_00421020* RRM20 (RNA recognition motif-containing protein 20) RNA recognition motif-containing protein 2 
TTHERM_00375130   Carboxyvinyl-carboxyphosphonate phosphorylmutase -related 1 
TTHERM_00840140   Kelch motif family protein 1 
TTHERM_00339620*† RPL40 (Ribosomal Protein of the Large Subunit #40) 
Homolog of Yeast RPL40; RPL40-Ubiquitin fusion protein; Ribosomal L40e family 
protein 2 
TTHERM_00577080  PGM1 (PhosphoGlucoMutase ) 
Phosphoglucomutase; carbohydrate metabolism enzyme that catalyzes the conversion 
of alpha-D-glucose 1-phosphate into alpha-D-glucose 6-phosphate; knock-out mutants 
have no defects in growth, morphology or exocytosis 
1 
TTHERM_00620980   hypothetical protein 1 
TTHERM_00105430*† PRF1 (PRoFilin) Profilin family protein; both inhibits and enhances actin polymerization; co-localizes with actin in the division furrow 1 
TTHERM_00449180*   hypothetical protein 1 
TTHERM_00522720† UBC9 (Ubiquitin conjugating enzyme 9) 
SUMO-conjugating enzyme involved in the Smt3p conjugation pathway; a member of 
the ubiquitin-conjugating enzyme E2 family 1 
TTHERM_00410130† SMT3 (Suppressor of Mif Two ) small ubiquitin-related modifier (SUMO), conjugated to lysine residues on target proteins, post-translational modification, 1 
TTHERM_00657560†   hypothetical protein 1 
TTHERM_00190830† DRH1 (DExD/H box RNA helicase 1) P68-like protein, putative 1 
TTHERM_00535260    succinyl-CoA synthetase, beta subunit family protein 1 
TTHERM_00456860   hypothetical protein 1 
* indicates the proteins that appeared in SUMO native purification 








Table 4: Ubc9 interacting proteins identified from 8-hour conjugating cells  
Gene Name Standard Name Description Times identified 
TTHERM_00522720†‡ UBC9 (Ubiquitin conjugating enzyme 9) 
SUMO-conjugating enzyme involved in the Smt3p conjugation pathway; a member of 
the ubiquitin-conjugating enzyme E2 family 2 
TTHERM_00410130†‡ SMT3 (Suppressor of Mif Two ) small ubiquitin-related modifier (SUMO), conjugated to lysine residues on target proteins, post-translational modification, 2 
TTHERM_00339620† RPL40 (Ribosomal Protein of the Large Subunit #40) 
Homolog of Yeast RPL40; RPL40-Ubiquitin fusion protein; Ribosomal L40e family 
protein 2 
TTHERM_00346560†   Ubiquitin family protein 2 
TTHERM_00085200†   Ubiquitin family protein 2 
TTHERM_01006550   Thioredoxin family protein 1 
TTHERM_00529790‡ CIT1 (CITrate synthase) 
Citrate synthase; bifunctional 14-nm filament-forming protein; structural protein 
involved in oral morphogenesis and pronuclear behavior during conjugation; citrate 
synthase activity decreased by polymerization and dephosphorylation 
2 
TTHERM_00622710‡   Pyridine nucleotide-disulphide oxidoreductase family protein 2 
TTHERM_00655820   translation elongation factor EF-1, subunit alpha 2 
TTHERM_00191720‡     2 
TTHERM_01044390† HSP71 (Heat Shock Protein ) Putative 70-kDa heat-shock protein (hsp70);  2 
TTHERM_00558440†‡ SSA5 (HSP70a paralog) dnaK protein 1 
TTHERM_00777260   hypothetical protein 2 
TTHERM_01084110   Glutamine synthetase 2 
TTHERM_00318570†   citrate synthase 2 
TTHERM_00666180†   conserved hypothetical protein 2 
TTHERM_00487140   hypothetical protein 1 
TTHERM_00433420†   Protein kinase domain containing protein. Sequence similarity to the PKA protein kinase family 2 





TTHERM_00551160† TDH1 (glyceraldehyde-3-phosphate dehydrogenase 1) Glyceraldehyde-3-phosphate dehydrogenase; metabolic enzyme involved in glycoloysis 2 
TTHERM_00697490 RPL14 (Ribosomal protein of the large subunit) Homolog of yeast RPL14/(RPL14e) 2 
TTHERM_01161040‡ TWI1 (Tetrahymena piWI ) 
PAZ/Piwi Domain protein similar to Piwi/Argonaute; required for accumulation of 
scnRNAs, elimination of IES and chromosome breakage during macronuclear 
development; interacts with scnRNAs; involved in histone H3 lysine 9/27 methylations 
2 
TTHERM_01084100†‡   Glutamine synthetase, catalytic domain containing protein 2 
TTHERM_00134940 RPL25 (Ribosomal Protein of the Large subunit #25) 
Homolog of Yeast RPL25, Human RPL23A, Bacteria RPL23; Ribosomal protein L23 
containing protein 1 
TTHERM_00494880‡   hypothetical protein 1 
TTHERM_00051840   hypothetical protein 2 
TTHERM_00849260‡   hypothetical protein 2 
TTHERM_00636970† RPP0 (Ribosomal Protein P0 of the large subunit) 
Homolog of yeast RPP0, human RPLP0, bacteria RPL10; Acidic ribosomal protein P0 of 
the large subunit 2 
TTHERM_00693060   enoyl-CoA hydratase/isomerase family protein 1 
TTHERM_00497380†   oxidoreductase, zinc-binding dehydrogenase family protein 2 
TTHERM_00434020   ribosomal protein S8.e containing protein 2 
TTHERM_01435670† GLC3 (GLC3 Ortholog) Alpha amylase, catalytic domain containing protein 2 
TTHERM_00624780   metallopeptidase family M24 containing protein 1 
TTHERM_00205180†‡   cyclic nucleotide-binding domain containing protein 2 
TTHERM_00497940† RRM34 (RNA recognition motif-containing protein 34)   2 
TTHERM_00402120†   Glutathione S-transferase, N-terminal domain containing protein 2 
TTHERM_00537300†   ribose-phosphate pyrophosphokinase family protein 1 
TTHERM_00105430† PRF1 (PRoFilin) Profilin family protein; both inhibits and enhances actin polymerization; co-localizes with actin in the division furrow 2 
TTHERM_00128870   hypothetical protein 1 





TTHERM_00348410‡   hypothetical protein 2 
TTHERM_00498190‡ HHF1 (Histone H Four ) 
Histone H4; one of the four histones (H2A, H2B, H3 and H4) that comprise the protein 
core of the eukaryotic nucleosome; adjacent to HHT2; encoded protein identical to 
Hhf2p; expressed during macronuclear S-phase 
2 
TTHERM_00484731 RRM28 (RNA recognition motif-containing protein 28) RNA recognition motif-containing protein 2 
TTHERM_00561680 RPL35 (Ribosomal Protein of the Large subunit #35) Homolog of Yeast RPL35, Bacterial RPL29 2 
TTHERM_00786930 NAP1 (Nucleosome Assembly Protein ) nucleosome assembly protein 2 
TTHERM_00943010 RPL31 (Ribosomal Protein of the Large subunit #31) Homolog of Yeast RPL31, Human RPL31 1 
TTHERM_00773690†   adenylosuccinate synthetase family protein 2 
TTHERM_01048110†   Glutamate/Leucine/Phenylalanine/Valine dehydrogenase family protein 1 
TTHERM_00499420 TGP1 (Tetrahymena G-DNA binding Protein ) 
G-quartet DNA binding protein; shows preference for binding parallel G-DNAs; activity 
localized predominantly in the nuclear fraction; knockout strain shows increased 
occurrence of extra micronuclei; not essential for growth 
2 
TTHERM_00195860†   Thiolase, N-terminal domain containing protein 2 
TTHERM_00657560†   hypothetical protein 2 
TTHERM_00283180 HTB2 (Histone h Two B ) Histone H2B; one of the four histones (H2A, H2B, H3 and H4) that comprise the protein core of the eukaryotic nucleosome; differs from Htb1p by three amino acids 1 
TTHERM_01207660 CDC2 (Cell Division Cycle ) 
Homolog of the catalytic subunit of the major cell cycle cyclin-dependent kinase (cdk); 
studies suggest cdc2p phosphorylates HHO1; expression positively regulated by HHO1 
phosphorylation during starvation, resulting in a positive feedback 
1 
TTHERM_00535740†   Mitochondrial carrier protein 1 
TTHERM_00339700†   hypothetical protein 1 
TTHERM_00499390†‡   Glycine cleavage system T protein. Sequence similarity to the HisK protein kinase family 2 
TTHERM_00052470†‡   AMP-binding enzyme family protein 1 
TTHERM_00444470†   S-adenosylmethionine synthetase family protein 2 





TTHERM_01108700 PGI1 (PhosphoGlucoIsomerase) Glycolytic enzyme phosphoglucose isomerase, catalyzes the interconversion of glucose-6-phosphate and fructose-6-phosphate. 2 
TTHERM_00475310†   hypothetical protein 2 
TTHERM_00530250   aldehyde dehydrogenase 1 
TTHERM_00118600† PYK1 (PYruvate Kinase) pyruvate kinase; converts phosphoenolpyruvate to pyruvate during glycolysis 2 
TTHERM_00437600   succinyl-CoA synthetase, beta subunit family protein 2 
TTHERM_01113100 RACK1 (Receptor for Activated C Kinase 1) Homolog of yeast ASC1 2 
TTHERM_00147510†   Coenzyme A transferase family protein 2 
TTHERM_00194240   homeobox-containing protein-related 1 
TTHERM_00448660†‡   hypothetical protein 1 
TTHERM_00927250‡   oxidoreductase, short chain dehydrogenase/reductase family protein 1 
TTHERM_00185350   ubiquitin-activating enzyme 1 
TTHERM_01035530    thioesterase family protein 1 
TTHERM_00243730†    Glucosamine-6-phosphate isomerase/6-phosphogluconolactonase family protein 2 
TTHERM_00433610   PCI domain containing protein 1 
TTHERM_00621400 TRM8 (tRNA methyltransferase 8) tRNA methyltransferase 1 
TTHERM_00241740   Thioredoxin family protein 1 
TTHERM_00429910†   cytidyltransferase-related domain containing protein 1 
TTHERM_00434040 RPS12 (Ribosomal Protein of the Small subunit ) 
Homolog of yeast RPS23, human RPS23 and bacterial RPS12; small (40S) ribosomal 
subunit protein with sequence similarity to E.coli ribosomal protein S12 2 
TTHERM_00836690†   Peptidase M16 inactive domain containing protein 2 
TTHERM_00133690† FRS1 (phenylalanyl-tRNA synthetase 1) phenylalanyl-tRNA synthetase, alpha subunit family protein 1 
TTHERM_00332160   hypothetical protein 1 





TTHERM_00220990‡   Protein kinase domain containing protein. Sequence similarity to a protein kinase family unique to Tetrahymena thermophila 1 
TTHERM_00148900‡   hypothetical protein 1 
TTHERM_00190830†‡ DRH1 (DExD/H box RNA helicase 1) P68-like protein, putative 1 
TTHERM_00382380†   AMP-binding enzyme family protein 2 
TTHERM_00549610‡ RPB81 (RNA polymerase II subunit 8A) Subunit shared in RNA polymerases I, II & III 1 
TTHERM_00149340† CCT2 (CCT2 Ortholog) TCP-1/cpn60 chaperonin family protein 1 
TTHERM_00790590‡   Protein kinase domain containing protein. Sequence similarity to the ULK protein kinase family 1 
TTHERM_00343440†   conserved hypothetical protein 1 
TTHERM_00614859†   conserved hypothetical protein 1 
TTHERM_00383610   Citrate synthase family protein 1 
TTHERM_00476640   Ribosomal protein L24e containing protein 1 
TTHERM_00046920†   TATA box-binding protein 1 
TTHERM_00464990   DNA topoisomerase family protein 1 
TTHERM_00035180†   acetoacetate decarboxylase 1 
TTHERM_00056140†‡ ERS3 (glutaminyl-tRNA synthetase 3) glutaminyl-tRNA synthetase family protein 1 
TTHERM_00780960 RPL27 (Ribosomal Protein of the Large subunit #27)   1 
TTHERM_00134940 RPL25 (Ribosomal Protein of the Large subunit #25) 
Homolog of Yeast RPL25, Human RPL23A, Bacteria RPL23; Ribosomal protein L23 
containing protein 1 
TTHERM_00660180‡ HMGB (High Mobility Group) 
High-Mobility-Group (HMG) protein; induces negative supercoiling of DNA in vitro; 
present in both macro- and micronuclei but with elevated expression during both 
macronuclear S phase and endoreplication of developing new macronuclei 
1 
TTHERM_00408760†‡   Ubiquitin carboxyl-terminal hydrolase family protein 1 
TTHERM_00023980†‡ RAN1 (RAN GTPase) Putative Ran GTPase; an evolutionarily conserved small GTPase with roles in nuclear transport, mitotic spindle assembly and nuclear envelope assembly 1 





TTHERM_00812780 RPL38 (Ribosomal Protein of the Large subunit #38) Homolog of Yeast RPL38 1 
TTHERM_00118610   ATP synthase F1, gamma subunit family protein 1 
TTHERM_00655520‡   Copper/zinc superoxide dismutase family protein 1 
† indicates proteins that appeared in Ubc9p native purification during vegetative growth 








Table 5: List of Ubc9p conjugation-specific interacting proteins in Tetrahymena.  
Gene Name Standard Name Description Times identified 
TTHERM_01006550  Thioredoxin family protein 1 
TTHERM_00529790 CIT1 (CITrate synthase) 
Citrate synthase; bifunctional 14-nm filament-forming protein; structural protein involved in 
oral morphogenesis and pronuclear behavior during conjugation; citrate synthase activity 
decreased by polymerization and dephosphorylation 
2  
TTHERM_00622710  Pyridine nucleotide-disulphide oxidoreductase family protein 2  
TTHERM_00655820  translation elongation factor EF-1, subunit alpha 2  
TTHERM_00191720   2  
TTHERM_00777260  hypothetical protein 2  
TTHERM_01084110  Glutamine synthetase 2  
TTHERM_00487140  hypothetical protein 1  
TTHERM_00160770 FTT49 (14-3-3 protein) 14-3-3 protein 1  
TTHERM_00697490 RPL14 (Ribosomal protein of the large subunit) Homolog of yeast RPL14/(RPL14e) 2 
 
TTHERM_01161040 TWI1 (Tetrahymena piWI ) 
PAZ/Piwi Domain protein similar to Piwi/Argonaute; required for accumulation of 
scnRNAs, elimination of IES and chromosome breakage during macronuclear development; 
interacts with scnRNAs; involved in histone H3 lysine 9/27 methylations 
2  
TTHERM_00134940 RPL25 (Ribosomal Protein of the Large subunit #25) 
Homolog of Yeast RPL25, Human RPL23A, Bacteria RPL23; Ribosomal protein L23 
containing protein 1 
 
TTHERM_00494880  hypothetical protein 1  
TTHERM_00051840  hypothetical protein 2  
TTHERM_00849260  hypothetical protein 2  
TTHERM_00693060  enoyl-CoA hydratase/isomerase family protein 1  
TTHERM_00434020  ribosomal protein S8.e containing protein 2  





TTHERM_00128870  hypothetical protein 1  
TTHERM_00600650 LBE1 (Lycopene Biosynthesis-Enhancing ) Lycopene biosynthesis-enhancing protein; similar to sigma cross-reacting protein 27A 1 
 
TTHERM_00348410  hypothetical protein 2  
TTHERM_00498190 HHF1 (Histone H Four ) 
Histone H4; one of the four histones (H2A, H2B, H3 and H4) that comprise the protein core 
of the eukaryotic nucleosome; adjacent to HHT2; encoded protein identical to Hhf2p; 
expressed during macronuclear S-phase 
2  
TTHERM_00484731 RRM28 (RNA recognition motif-containing protein 28) RNA recognition motif-containing protein 2 
 
TTHERM_00561680 RPL35 (Ribosomal Protein of the Large subunit #35) Homolog of Yeast RPL35, Bacterial RPL29 2 
 
TTHERM_00786930 NAP1 (Nucleosome Assembly Protein ) nucleosome assembly protein 2 
 
TTHERM_00943010 RPL31 (Ribosomal Protein of the Large subunit #31) Homolog of Yeast RPL31, Human RPL31 1 
 
TTHERM_00499420 TGP1 (Tetrahymena G-DNA binding Protein ) 
G-quartet DNA binding protein; shows preference for binding parallel G-DNAs; activity 
localized predominantly in the nuclear fraction; knockout strain shows increased occurrence 
of extra micronuclei; not essential for growth 
2  
TTHERM_00283180 HTB2 (Histone h Two B ) Histone H2B; one of the four histones (H2A, H2B, H3 and H4) that comprise the protein core of the eukaryotic nucleosome; differs from Htb1p by three amino acids 1 
 
TTHERM_01207660 CDC2 (Cell Division Cycle ) 
Homolog of the catalytic subunit of the major cell cycle cyclin-dependent kinase (cdk); 
studies suggest cdc2p phosphorylates HHO1; expression positively regulated by HHO1 
phosphorylation during starvation, resulting in a positive feedback 
1  
TTHERM_01108700 PGI1 (PhosphoGlucoIsomerase) Glycolytic enzyme phosphoglucose isomerase, catalyzes the interconversion of glucose-6-phosphate and fructose-6-phosphate. 2 
 
TTHERM_00530250  aldehyde dehydrogenase 1  
TTHERM_00437600  succinyl-CoA synthetase, beta subunit family protein 2  
TTHERM_01113100 RACK1 (Receptor for Activated C Kinase 1) Homolog of yeast ASC1 2 
 
TTHERM_00194240  homeobox-containing protein-related 1  
TTHERM_00927250  oxidoreductase, short chain dehydrogenase/reductase family protein 1  
TTHERM_00185350  ubiquitin-activating enzyme 1  
TTHERM_01035530   thioesterase family protein 1  





TTHERM_00621400 TRM8 (tRNA methyltransferase 8) tRNA methyltransferase 1 
 
TTHERM_00241740  Thioredoxin family protein 1  
TTHERM_00434040 RPS12 (Ribosomal Protein of the Small subunit ) 
Homolog of yeast RPS23, human RPS23 and bacterial RPS12; small (40S) ribosomal 
subunit protein with sequence similarity to E.coli ribosomal protein S12 2 
 
TTHERM_00332160  hypothetical protein 1  
TTHERM_00220990  Protein kinase domain containing protein. Sequence similarity to a protein kinase family unique to Tetrahymena thermophila 1 
 
TTHERM_00148900  hypothetical protein 1  
TTHERM_00549610 RPB81 (RNA polymerase II subunit 8A) Subunit shared in RNA polymerases I, II & III 1 
 
TTHERM_00790590  Protein kinase domain containing protein. Sequence similarity to the ULK protein kinase family 1 
 
TTHERM_00383610  Citrate synthase family protein 1  
TTHERM_00476640  Ribosomal protein L24e containing protein 1  
TTHERM_00464990  DNA topoisomerase family protein 1  
TTHERM_00780960 RPL27 (Ribosomal Protein of the Large subunit #27)  1 
 
TTHERM_00134940 RPL25 (Ribosomal Protein of the Large subunit #25) 
Homolog of Yeast RPL25, Human RPL23A, Bacteria RPL23; Ribosomal protein L23 
containing protein 1 
 
TTHERM_00660180 HMGB (High Mobility Group) 
High-Mobility-Group (HMG) protein; induces negative supercoiling of DNA in vitro; 
present in both macro- and micronuclei but with elevated expression during both 
macronuclear S phase and endoreplication of developing new macronuclei 
1  
TTHERM_00812780 RPL38 (Ribosomal Protein of the Large subunit #38) Homolog of Yeast RPL38 1 
 
TTHERM_00118610  ATP synthase F1, gamma subunit family protein 1  







Table 6: Putative “junk” proteins that appeared in three unrelated Tetrahymena purifications. 
Gene Name Standard Name Description 
TTHERM_00194650 TRS1 (Threonyl-tRNA synthetase 1) threonyl-tRNA synthetase family protein 
TTHERM_00794020   glycine dehydrogenase family protein 
TTHERM_00105110 HSP70 (Heat Shock Protein ) Putative 70-kDa heat-shock protein (hsp70) 
TTHERM_00171850 SSA6 (HSP70a paralog) dnak protein BiP 
TTHERM_00926980   acetyl-CoA acyltransferases family protein 
TTHERM_00114360 SRS1 (seryl-tRNA synthetase 1) seryl-tRNA synthetase family protein 
TTHERM_00353280   adenosylhomocysteinase family protein 
TTHERM_00158520 HSP82 (Heat Shock Protein ) Hsp90 family member; 82 kDa heat shock-inducible protein 
TTHERM_00047080   succinate dehydrogenase, flavoprotein subunit containing protein 
TTHERM_00794110   dehydrogenase, isocitrate/isopropylmalate family protein 
TTHERM_00268070   2-oxoglutarate dehydrogenase, E1 component family protein 
TTHERM_00190950 ACT1 (ACTin) Actin; structural protein; monomeric subunits of the actin protein (G-actin) polymerize to form structural filiaments (F-actin); localized to the cleavage forrow during cytokinesis 
TTHERM_01049200   Glutamate/Leucine/Phenylalanine/Valine dehydrogenase family protein 
TTHERM_00128330   Amylo-alpha-1,6-glucosidase family protein 
TTHERM_01084370 TPA8 (Tetrahymena P-type ATPase ) 
P-type ATPase; putative sarco(endo)plasmic reticulum Ca(2+) ATPase (SERCA); constitutively 
expressed; starvation downregulates expression 
TTHERM_00196370 HSP60 (Heat Shock Protein) HSP60; TCP-1/cpn60 chaperonin family protein 
TTHERM_01014750   dnaK protein 
TTHERM_00052310 AAC (ADP/ATP Carrier) Hydrogenosomal ADP/ATP carrier protein 
TTHERM_00954380   2-oxoglutarate dehydrogenase, E1 component family protein 
TTHERM_00241700   succinate dehydrogenase and fumarate reductase iron-sulfur protein 





TTHERM_00043870 TGP2 (Tetrahymena G-DNA binding Protein ) 
G-quartet DNA binding protein; has dihydrolipoamide dehydrogenase (DLDH) activity; preferentially 
binds G4-DNA oligonucleotides with adjacent single-stranded domains 
TTHERM_00151810   Elongation factor Tu, mitochondrial precursor, putative 
TTHERM_00059330   hypothetical protein 
TTHERM_00616050 DRS1 (Aspartyl-tRNA synthetase 1) aspartyl-tRNA synthetase family protein 
TTHERM_00535260   succinyl-CoA synthetase, beta subunit family protein 
TTHERM_00695650   AMP-binding enzyme family protein 
TTHERM_00237560   AMP-binding enzyme family protein 
TTHERM_00571650   hypothetical protein 
TTHERM_00221140 ARS2 (alanyl-tRNA synthetase 2) alanyl-tRNA synthetase family protein 
TTHERM_00899460   acetyl-CoA acyltransferases family protein 
TTHERM_00487020 PRS1 (Prolyl-tRNA synthetase 1) prolyl-tRNA synthetase family protein 
TTHERM_00938820 EEF2 (Eukaryotic translation Elongation Factor ) 
Translation elongation factor 2; catalyzes ribosomal translocation during protein synthesis; mRNA is 
expressed during vegetative growth; high amino acid identity with EF-2 in other eukaryotes 
TTHERM_00864870   hypothetical protein 
TTHERM_00486480 ENO1 (ENOlase) Enolase; portions of this gene may have been laterally transferred 
TTHERM_00122290 TCP1 (TCP1 Ortholog) TCP-1/cpn60 chaperonin family protein 
TTHERM_00529860 VMA2 (Vacuolar Membrane Atpase) V-type ATPase, B subunit family protein 
TTHERM_00193230 PDA1 (Pyruvate Dehydrogenase Alpha 1) 
pyruvate dehydrogenase complex E1 component, catalyzes the direct oxidative decarboxylation of 
pyruvate to acetyl-CoA 
TTHERM_00691520 KRS1 (lysyl-tRNA synthetase) lysyl-tRNA synthetase family protein 
TTHERM_00339640 VMA1 (Vacuolar Membrane Atpase) V-type ATPase, A subunit family protein 
TTHERM_00691890 NRS1 (asparaginyl-tRNA synthetase 1) asparaginyl-tRNA synthetase family protein 
TTHERM_00037060 CCT8 (CCT8 Ortholog) TCP-1/cpn60 chaperonin family protein 
TTHERM_00469380 DRH14 (DExD/H box RNA helicase 14) DEAD/DEAH box helicase family protein 
TTHERM_00429890   hypothetical protein 





TTHERM_00193640   2-oxoglutarate dehydrogenase, E1 component family protein 
TTHERM_00068140   succinyl-CoA synthetase, alpha subunit family protein 
TTHERM_00616340   HEAT repeat family protein 
TTHERM_01394370   hypothetical protein 
TTHERM_00239290 CCT3 (CCT3 Ortholog) TCP-1/cpn60 chaperonin family protein 
TTHERM_00859260   EF-1 guanine nucleotide exchange domain containing protein 
TTHERM_00723390   dehydrogenase, isocitrate/isopropylmalate family protein 
TTHERM_00013760   hypothetical protein 
TTHERM_00365340   AAA family ATPase, CDC48 subfamily protein 
TTHERM_00046920   TATA box-binding protein 
TTHERM_00344030   dehydrogenase, isocitrate/isopropylmalate family protein 
TTHERM_00037050 CCT4 (CCT4 Ortholog) TCP-1/cpn60 chaperonin family protein 
TTHERM_00979780   Transketolase, pyridine binding domain containing protein 
TTHERM_01197120 DRH18 (DExD/H box RNA helicase 18) DEAD/DEAH box helicase family protein 
TTHERM_00151670   oxidoreductase, zinc-binding dehydrogenase family protein 
TTHERM_00802450   Mitochondrial carrier protein 
TTHERM_00502240   Carbamoyl-phosphate synthase L chain, ATP binding domain containing protein 
TTHERM_00285620   NAC domain containing protein 
TTHERM_00474970   60s Acidic ribosomal protein 
TTHERM_00549480   Thioredoxin family protein 
TTHERM_00497960 CCT7 (Chaperonin Containing TCP-1 ) CCT-eta chaperonin subunit; expressed during cilia biogenesis and conjugation 
TTHERM_00338470 PFK3 (PhosphoFructoKinase) Alpha subunit of heterooctameric phosphofructokinase 





TTHERM_00363210   Mitochondrial carrier protein 
TTHERM_00670500 CCT6 (CCT6 Ortholog) TCP-1/cpn60 chaperonin family protein 
TTHERM_00459390   CTP synthase family protein 
TTHERM_00735240   small GTP-binding protein domain containing protein 
TTHERM_00134970 CCT5 (CCT5 Ortholog) TCP-1/cpn60 chaperonin family protein 
TTHERM_00925340   hypothetical protein 
TTHERM_00998940   hypothetical protein 
TTHERM_00046480 ENO2 (ENOlase) enolase family protein 
TTHERM_00028740 RPL12 (Ribosomal Protein of the Large subunit #12) 
Homolog of Yeast RPL12, Human RPL12, Bacterial RPL11; Ribosomal protein L11; RNA binding 
domain containing protein 
TTHERM_00829380 RPL11 (Ribosomal protein of the large subunit) Homolog of yeast RPL11(/RPL5)and E.coli RPL5 
TTHERM_00275740 CHC1 (Clathrin Heavy Chain-like protein) Region in Clathrin and VPS family protein 
TTHERM_00338460 PFK2 (PhosphoFructoKinase) Beta subunit of heterooctameric Phosphofructokinase 
TTHERM_00715730   Calpain family cysteine protease containing protein 
TTHERM_00476820   TIP49 C-terminus family protein 
TTHERM_00377330   hypothetical protein 
TTHERM_00049030   Na,H/K antiporter P-type ATPase, alpha subunit family protein 
TTHERM_00659010   hypothetical protein 
TTHERM_00584700   Protein kinase domain. Sequence similarity to a protein kinase family unique to Tetrahymena thermophila  
TTHERM_00725990   hypothetical protein 
TTHERM_00657270 RRS1 (arginyl-tRNA synthetase 1) arginyl-tRNA synthetase family protein 
TTHERM_00268030   Polyprenyl synthetase family protein 
TTHERM_00527090   PBS lyase HEAT-like repeat family protein 
TTHERM_00773720   hypothetical protein 





TTHERM_00047230   hypothetical protein 
TTHERM_00161250   hypothetical protein 
TTHERM_00865270   DnaJ domain containing protein 
TTHERM_01513260 BBC49 hypothetical protein 
TTHERM_00929450 PGK1 (PhosphoGlycerate Kinase ) 
Phosphoglycerate kinase; glycolytic enzyme that catalyzes the conversion of 3-phospho-D-glycerate to 3-
phospho-D-glyceroyl phosphate 
TTHERM_00114360 SRS1 (seryl-tRNA synthetase 1) seryl-tRNA synthetase family protein 
TTHERM_00317440 
MFE1 (Fusion of peroxisomal 
multifunctional oxydation 
protein and 2-enoyl-CoA 
hydratase) 
Fusion of peroxisomal multifunctional oxydation protein and 2-enoyl-CoA hydratase 
TTHERM_00052400   Cystathionine beta-lyase 
TTHERM_00131110 RPS18 (Ribosomal Protein of the Small subunit 18) Homolog of yeast RPS18, human RPS18, bacterial RPS13 
TTHERM_00823670 RPS19 (Ribosomal Protein of the Small subunit 19) Homolog of yeast RPS19, human RPS19; 
TTHERM_00149300 RPS4 (Ribosomal Protein of the Small subunit 4) Homolog of yeast RPS4, human RPS4; 
TTHERM_00454080 RPS22 (Ribosomal Protein of the Small subunit 22) Homolog of yeast RPS22, bacterial RPS8; 
TTHERM_01146030 CAT1 (CATalase ) Catalase; peroxisomal enzyme involved in the metabolism of hydrogen peroxide; enzyme activity induced by linolenic acid 
TTHERM_00762890 RPS17 (Ribosomal Protein of the Small subunit 17) Homolog of yeast RPS17, human RPS17 
TTHERM_00475140 PDI1 (Protein Disulfide-Isomerase) protein disulfide-isomerase domain containing protein 
TTHERM_00777250   hypothetical protein 







CHAPTER 4 DISCUSSION AND FUTURE PERSPECTIVE 
Since the discovery of SUMO in 1996, efforts have been focused on the identification of 
its cellular targets in order to characterize the functional consequences of SUMOylation. 
In this study, we combined phenotypic study as well as proteomic study to elucidate 
cellular functions of SUMOylation in Tetrahymena thermophila during vegetative growth 
and sexual reproduction. Our proteomic analyses and genetic analyses all support roles of 
SUMOylation in regulating mitosis, metabolism, ribosome biogenesis, progression 
through conjugation, heat shock response and MAC development. 
Ubc9p regulates cell cycle progression and chromosomal segregation 
One of the first roles discovered for SUMOylation was in regulation of the cell cycle 
progression in numerous model systems [99,149,150]. We have demonstrated that there 
is a requirement for SUMOylation in Tetrahymena mitosis. We found that complete 
deletion of UBC9 was lethal, a result consistent with studies in other organisms 
[13,38,48,136]. However, reduced expression of UBC9 resulted in distinct phenotypes in 
MICs. The MICs were lost from UBC9-depleted cells during vegetative growth. Having a 
separate mitotic nucleus that does not contribute to gene expression makes Tetrahymena 
a unique system for this study as other organisms will die aneuploidy nuclei. Our model 
is that there is little to no DNA that is distributed to the MIC during mitosis due to 
chromosome mis-segregation events that occur as a result of UBC9 depletion. This is 
supported by the observation of unequal signal in dividing nuclei in DAPI stained cells 
during mitosis (Fig. 8C). The requirement for SUMOylation in chromosome segregation 
is well established in other species [45,109,151,152]. In budding yeast, deficiency in 
SUMOylation brought upon by deletion of UBC9 results in gross defects in chromosome 
structure and integrity as well as aberrant segregation and polyploidy [39]. On the other 




negative Ubc9p have multiple MICs. This could be explained if dominant-negative Ubc9 
expression prevents MAC division and/or cytokinesis but MIC division is unaffected. In 
this case, the single MIC undergoes one or more divisions without cytokinesis occurring 
which would indicate a requirement of SUMOylation in cytokinesis. A multi-nucleate 
phenotype was observed by Hayashi et al in a large number of chicken cells expressing a 
conditional UBC9 mutant [38]. Septins are proteins have that been identified as high 
abundant substrates of SUMO in budding yeast during mitosis. Septins are SUMO-
modified prior to anaphase and disappear abruptly at cytokinesis. Only SUMOylated 
septins have been observed to accumulate at the bud neck in mother cells[153] in yeast. 
These results all suggest that Ubc9p plays an indispensable role in Tetrahymena mitosis 
either through regulating cytokinesis or controlling chromosome segregation.  
In agreement with the diverse cell cycle defects in SUMO mutants in model systems, we 
identified a Cell Division Cycle protein 2 (CDC2) as an Ubc9p interacting partner in our 
proteomic screen. CDC2, also known as cyclin dependent kinase 1 (Cdk1), is a key 
regulator in cell cycle regulation that functions as a serine/threonine kinase [154]. It is 
possible that SUMOylation of Cdc2 is necessary for its role in regulating progression of 
the cell cycle. Alternatively, Ubc9 in Tetrahymena may be a substrate of Cdc2 
phosphorylation as it is in human [155]. Another Ubc9p interacting protein that we 
identified is DNA topoisomerase I (TOPO I) which has been previously reported as 
SUMO substrate, as well as a Ubc9 interacting protein [156].  TOPO I was SUMO 
conjugated in a Ubc9p-dependent manner and its interaction with SUMO and Ubc9p was 
required for TOPO I-mediated DNA damage repair.  
This loss-of-MIC phenotype is particularly interesting to us, because it has not been 
reported previously in other species. We have observed Tetrahymena cells devoid of 
DAPI-detectable MICs are able to survive with a micronucleus that does not have DNA, 
which makes it a unique organism that provides more opportunity to study genome 
integrity. A similar mitotic phenotype has been described previously by Cui and 
Gorovsky in Tetrahymena [157] where they identified a centromeric H3 protein, Cna1p, 




mitosis when CNA1 gene was partially knockdown in somatic macronucleus. CNA1 gene 
encodes a centromere-specific histone H3 variants, termed CenH3s [158-160], that is 
associated with centromeric DNA in place of the typical H3s associated with the rest of 
the genome. CenH3s are functionally conserved [161] and are required for functional 
centromeres and recruitment of other centromeric and spindle checkpoint proteins. CNA1 
is essential for vegetative growth. Incomplete macronuclear knockout results in MICs 
that are smaller than MICs in wild-type cells [157], rather than the loss-of-MIC 
phenotype observed in our Ubc9p depletion cells. Small MICs do not seem to prevent 
MIC mitosis, however, DNA is unequally distributed to daughter nuclei [157], which is 
in line with our observation in cells with reduced expression of Ubc9p. There is evidence 
that SUMOylation plays critical roles in centromere function. Saccharomyces cerevisiae 
Slx5/8 complex is the founding member of a recently defined class of SUMO-targeted 
ubiquitin ligases (STUbLs). Slx5 exhibits a unique centromeric location though genome-
wide biding analysis. Deletion of slx5 and slx 8 in yeast show severe mitotic defects that 
include aneuploidy and spindle mispositioning. Yeast two-hybrid screening has identified 
that Ubc9 interacts with three subunits of the S. cerevisiae centromere DNA-binding core 
complex, CBF3 [122]. All of these point towards the role of SUMOylation in 
centromere-specific functions during mitosis. It would be interesting to analyze whether 
Cnap1 is a SUMOylation substrate. 
Howard-Till et al have recently identified a protein that is part of the cohesion 
components, termed Rec8 [162], which is shown to localize to mitotic and meiotic nuclei. 
RNAi-induced depletion of Rec8 results in slow growth, as well as lagging chromosomes 
in mitotic anaphase [162]. Immunoprecipitation of Rec8 followed by probing with anti-
SUMO antibody suggests that Rec8 is SUMOylated (R. Howard-Till personal 
communication). This provides another model where SUMOylation regulates cohesion 
which further controls chromosomal segregation.    
SUMOylation in Tetrahymena conjugation 
Tetrahymena thermophila increase transcript levels of SUMO pathway enzymes during 




processes that occur during conjugation. Our studies demonstrate critical roles for Ubc9p 
during the sexual life cycle of Tetrahymena. Crosses between cell lines that express the 
dominant negative Ubc9 were delayed in meiosis and resulted in fewer true exconjugant 
progeny than from wild-type controls (Shown in Table 2). In contrast, cell lines that were 
depleted for Ubc9p did not form pairs and therefore could not complete any of the 
subsequent stages of conjugation including meiosis and macronuclear development. This 
non-pairing phenotype was unexpected yet there is precedent for a SUMOylation 
requirement for mating in other species. In budding yeast, degradation of the yeast 
mating type factor, α1 protein, requires SUMO Targeted Ubiquitin Ligases (STUbLs) 
Slx5 and Slx8 [163]. The requirement for SUMOylation could result from direct 
modification of protein in cell pairing, a signal transduction pathway or a transcriptional 
pathway needed to produce mating proteins. Although future studies will be required to 
evaluate these possibilities we can note one observation made from an abandoned project. 
In an earlier study, we identified three SUMO E3 ligase candidates based on 
domains/structures (Q. Yang and J. Forney unpublished data). Cell lines expressing GFP-
E3#3 (Candidate 3) were generated and we found that the fusion protein localized at the 
junctions of conjugating cells. It is possible that candidate 3 is a SUMO E3 ligase that 
transfers SUMO to targets that are required for cell pairing. At that time we were 
expecting nuclear SUMO E3 ligases so we did not pursue studies of this protein but in 
view of the non-pairing phenotype this could be significant. The non-pairing phenotype 
and delay in meiosis prevented us from analyzing the role of SUMOylation during 
macronuclear development. To overcome this problem, future efforts will be focused on 
developing alternative approaches such as inducible RNAi knockdown of SUMO 
pathway genes or examination of SUMO substrate proteins during conjugation. 
Ultimately we anticipate that severe defects will be discovered upon depletion of SUMO 
pathway proteins. Previous studies demonstrated that RNAi-based silencing of Uba2p 
and SUMO in Paramecium tetraurelia prevented the excision of IES during formation of 
the somatic macronucleus [126]. Several conjugation-specific Ubc9 interacting proteins 




an argonaute protein that is required in RNAi-mediated DNA rearrangements in 
Tetrahymena macronuclear development [120].  
Many known SUMO substrates regulate nuclear activity, including roles in transcription, 
chromatin remodeling, DNA/RNA modification and DNA repair [164]. Surprisingly, 
only a small fraction of the Ubc9p interacting proteins were classified as nuclear proteins 
(~7 from vegetative cells and ~12 from mated samples). The reasons for this are unclear 
but future efforts to identify additional nuclear Ubc9p interacting proteins may require 
the purification of nuclei followed by protein purification and protein mass spectrometry.  
Identification of Ubc9 interacting proteins using proteomics-based approach 
Prior to 2004, identification of Ubc9p interacting protein was on performed using mostly 
yeast two-hybrid screens and limited numbers of proteins were identified. However, the 
discovery of proteomics methods dramatically changed this. One challenge that we are 
constantly facing is that SUMOylation is a dynamic process with conjugation and de-
conjugation taking place concurrently, which means that at a given time in the cell, the 
form of a particular substrate attached to Ubc9p or SUMO is present in very low 
quantities, making detection of such protein-protein interactions very difficult. In 
addition, different proteins will be SUMOylated under different cellular conditions at 
different times. All these factors make it impossible for any single study to be 
comprehensive. We are focusing on identification of Ubc9p interacting proteins during 
Tetrahymena vegetative growth vs sexual reproduction. Ubc9p was N-terminal tagged 
with (His)6 followed by (FLAG)3 tag. Purification was performed under native conditions 
to protect the integrity of the protein complexes, followed by LC-MS protein mass 
spectrometry.  We identified 242 proteins from vegetative cells and 213 proteins from 
conjugating samples. To verify the authenticity of these proteins as true interactors is 
another challenge. One source of background is from high abundant “sticky” proteins. In 
order to identify these “sticky” proteins and increase our confidence, we compared 
proteins that we identified against those from two other Tetrahymena purifications 
performed by Gould et al. and Smith et al. Proteins that appear in all three purifications 




our Ubc9p proteomic screen (they are not present in the two studies) are high-confidence 
proteins. We have identified 128 such high confidence proteins from vegetative samples 
(Veg.) and 106 from conjugating Tetrahymena (Conj.) (Table 7). In addition to a large 
number of novel Ubc9p interacting proteins identified, the list includes orthologs of 
previously identified Ubc9p interacting proteins or SUMO conjugates in other organisms 
(e.g. Cdc2, TopI, EEF2, DRH19, multiple aminoacyl-tRNA synthetases and ribosomal 
proteins) 
Table 7: Comparison between numbers of proteins identified from 
vegetative vs conjugating Tetrahymena based on biological function. 
 Veg. Conj. 
Metabolism 36 31 
PTM & degradation 13 11 
Signal transduction 4 2 
Ribosome biogenesis 2 12 
RNA processing 8 5 
Translation 4 1 
Structure maintenance 2 2 
Response to cellular environment 10 4 
Unknown 39 24 
Transcription 4 4 
Cell division 1 2 
Transport 5 4 
Chromatin remodeling 0 2 
Tetrahymena Conjugation 0 2 
Total 128 106 
 
As shown in table 6, no proteins that are involved in chromatin remodeling and 
Tetrahymena conjugation were identified from vegetative samples, while 2 proteins in 
chromatin remodeling and 2 proteins involved in Tetrahymena conjugation were 
identified from conjugating samples. In addition, increased numbers of ribosomal 
proteins were identified in conjugating samples compares to vegetative samples (12 vs 2).  
In 2013, Dr. Brian Raught’s laboratory reported 97 high-confidence Ubc9p interacting 
proteins in budding yeast using affinity purification-coupled mass spectrometry approach 




have previously been identified as SUMO conjugants. Table 8 categorizes proteins 
identified in yeast (S.c.) and Tetrahymena (T.t) based on their biological functions. 
Table 8: Numbers of Ubc9 interacting proteins identified from 
Ubc9p proteomics screens between Tetrahymena and yeast 
 T.t S.c 
Metabolism 36 19 
PTM & degradation 13 1 
Signal transduction 4 0 
Ribosome biogenesis 2 21 
RNA processing 8 9 
Translation 4 5 
Structure maintenance 2 3 
Response to cellular environment 10 1 
Unknown 39 8 
Transcription 4 9 
Cell division 1 5 
Transport 5 7 
Bud site selection 0 2 
chromatin remodeling 0 7 
Total 128 97 
 
Many known SUMO substrates regulate nuclear activity, including roles in transcription, 
chromatin remodeling, DNA/RNA modification and DNA repair [164]. Surprisingly, 
only a small fraction of the Ubc9 interacting proteins were classified as nuclear proteins 
(~7 from vegetative cells and ~12 from mated samples). The reasons for this are unclear 
but future efforts to identify additional nuclear Ubc9p interacting proteins may require 
the purification of nuclei followed by protein purification and protein mass spectrometry.  
There is increasing evidence, however, that suggests SUMOylation is a less-centralized 
process than expected and regulates several processes outside the nucleus including 
membrane transport, mitochondrial activity, ribosomal biogenesis and heat shock stress 
[6-8,91,165]. Indeed we identified several proteins that are involved in these processes.  
SUMOylation and metabolism 
Almost half of the Ubc9p interacting proteins we identified are classified as proteins in 




SUMO is known to modify and affect the function or regulate specific metabolic 
enzymes within pathways. There is increasing evidence that SUMO is a key factor in 
facilitating energy and nucleotide metabolism in response to cellular and environmental 
cues, one such example is hypoxia [166]. Under the condition of hypoxia, increased 
protein SUMOylation is observed. In addition, under hibernation, torpor and focal 
cerebral ischaemia conditions, increased protein SUMOylation is also observed 
[167,168]. These studies demonstrated that global protein SUMOylation is increased in 
response to metabolic stress despite the fact that specific targets under these conditions 
were not identified. A proposed model is that the basis of hypoxia-dependent increase in 
global SUMOylation appears to involve, at least in part, transcriptional upregulation of 
SUMO mRNA [166,169]. Researchers have also identified Hypoxia-induced factor (HIF) 
as a SUMO substrate [169]. HIF is a central transcriptional regulator of a cell’s adaptive 
response to hypoxia [170]. The regulation of transcriptional activity by SUMOylation 
during hypoxic stress is one of the first observations establishing the relationship between 
SUMOylation and metabolic stress response. 
A second way by which the SUMO pathway may have an impact on metabolic processes 
is through the regulation of the balance between mitochondrial fission and fusion, which 
is critical for a number of processes including the maintenance of numbers of neuronal 
synapses [2,171]. Several mitochondria proteins have been identified from our 
immunoaffinity purification. They are either located in the mitochondrion (e.g. citrate 
synthase), or they are involved in mitochondrial-related process (e.g. Mitochondrial 
carrier protein). 
SUMOylation and ribosomal biogenesis 
The control of ribosome biogenesis is a critical cellular nodal point, which ensures that 
protein synthesis is coordinated with cell growth and proliferation. The process is 
initiated in the nucleolus, where the precursor forms of the small 40S and larger 60S 
subunits are generated. Following cleavage and processing, these subunits are exported to 
the cytoplasm for assembly into ribosomes. In the yeast Saccharomyces cerevisiae, 




biogenesis pathway. Other biochemical approaches have enabled the isolation of specific 
ribosomal pre-40S and pre-60S sub-complexes, which seem to function as intermediates 
in the export of ribosomal particles to the cytoplasm [172]. Genetic studies in yeast also 
revealed a role of the ubiquitin-like SUMO system in the formation and nuclear export of 
pre-ribosomal particles [91]. Crucial roles of SUMOylation in mammalian ribosome 
biogenesis have also been described [93,173]. We identified numerous proteins of the 
ribosome complex in our proteomic screen in both vegetative and mating cells. 
Moreover, we identified more proteins in the mated sample corresponding to MAC 
development which would indicate the increased requirement of SUMO in protein 
expression. We cannot differentiate whether these proteins are modified by SUMO in the 
nucleus or in the cytoplasm but analysis of substrates prepared from nuclear extracts may 
aid in differentiating between these alternatives. 
SUMOylation and heat shock stress 
All organisms need to be able to sense and react to extreme environmental conditions. 
Without appropriate response such stresses can lead to cell damage or death. The heat 
shock response is one of the most conserved and well-studied defense mechanism. 
SUMOylation has been shown to involve in heat shock response. The levels of SUMO1 
and SUMO2 conjugates were increased substantially followed the induction of heat 
shock in Arabidopsis [174]. Overexpression of SUMO2 enhanced steady state levels of 
SUMO2 conjugates in heat shock-induced accumulation. This accumulation was reduced 
in an Arabidopsis line modified for increased thermotolerence by overexpressing the 
cytosolic isoform of the Heat shock protein 70 (HSP70) chaperonin [174]. Following the 
heat stress, SUMO conjugates pool were drastically increased in plants [164]. RNAi 
knockdown of SUMO2 and SUMO3 substantially reduced cell survival after heat shock 
[165]. In 2009, the Hay group utilized a system-level proteomics approach to describe 
quantitative changed in protein modification with the SUMO2 paralog in mammalian 
cells during response to heat shock. A massive redistribution of SUMO2 conjugates was 




such as Hsp70 and Hsp71, were identified as Ubc9 interacting proteins in Tetrahymena 
which is consistent with the role of SUMOylation in heat shock response.    
Identification of SUMO interacting protein under native condition.  
As an alternative approach to identify SUMO substrates, affinity purification of SUMO 
protein was carried out to identify SUMO interacting proteins. SUMO was tagged with 
the same dual tag that we described above (Q. Yang and J. Forney unpublished data). 78 
proteins were identified, which includes proteins from several cellular processes, such as 
metabolism, ribosome biogenesis, transcription, and stress response (Fig. 21 and Table 
9). We compared Ubc9p vegetative list and SUMO vegetative list and found large 
amount of proteins (52) that are common to both data sets (Fig. 22). There are two ways 
to interpret these overlapping proteins - some of these are potential SUMO substrates or 
SUMO E3 ligases that are interacting with both Ubc9p and SUMO, or it is also plausible 
that these proteins represent background proteins present in both proteomic screens. 
 
Fig. 21: Graphical representation of biological processes of SUMO interacting 
proteins in Tetrahymena. 78 high-confidence SUMO interacting proteins were reported. 
These proteins are categorized into different subsets based on their major functions, 
including transcription, response to cellular environment, structure maintenance, 
metabolism, translation, transport, ribosome biogenesis, RNA processing, PTM & 





Fig. 22: Overlap between Ubc9p native purification and SUMO native purification 
during Tetrahymena vegetative growth. There are 52 proteins that appeared in both 
Ubc9 and SUMO two-step purifications.  
 
Table 9: Number of proteins categorized by biological functions from 
Ubc9p and SUMO proteomics screens 
 Ubc9p SUMO 
Metabolism 36 20 
PTM & degradation 13 7 
Signal transduction 4 2 
Ribosome biogenesis 2 1 
RNA processing 8 5 
Translation 4 2 
Structure maintenance 2 2 
Response to cellular environment 10 7 
Unknown 39 27 
Transcription 4 3 
Cell division 1 0 
Transport 5 2 
Total 128 78 
 
Future perspectives 
Different phenotypes were observed from cell lines depleted with Ubc9p (loss of MIC 
phenotype) and cell lines expressing catalytic inactive Ubc9p (multiple MICs phenotype). 




segregation, however, the cause of multiple micronuclei was unclear. One hypothesis is 
that cells expressing catalytic inactive Ubc9p causes defects in cytokinesis. Monitoring 
cell number at various time points will provide initial evidence whether cytokinesis is 
affected or not. One of the most abundant SUMOylated protein in budding yeast is septin 
[175]. SUMO conjugation of septins is required for bud-neck ring formation during 
cytokinesis [176]. It would be interesting to investigate SUMOylation of septins in the 
cells expressing catalytic inactive Ubc9p.  
Validation and characteristic of Ubc9p interacting proteins 
TWI1 and HMGB were identified as conjugation-specific Ubc9p interacting proteins. 
TWI1 is required for IES elimination in Tetrahymena macronuclear development [119]. 
In HMGB depleted Tetrahymena cells, mating was delayed and mating efficiency was 
decreased [148]. We anticipate Ubc9p is required during Tetrahymena conjugation. Two 
additional methods will be employed to validate interaction between Ubc9p and TWI1 or 
HMGB. The first approach will validate Ubc9p interaction with TWI1 or HMGB by co-
immunoprecipitation. Specifically, samples either wild-type untagged strain, tandem-
affinity purified Ubc9p preparation will be separated by SDS-PAGE. Following this, 
western blot analyses will be performed for TWI1 and HMGB using antibodies if they 
are readily available. If antibodies are not available, we can express HA- or GST- tagged 
TWI1 or HMGB. Western blotting can then be performed with anti-HA or anti-GST 
antibody. A band corresponding to Twi1 or HMGB is expected in the Ubc9p preparation 
as opposed to the control preparation. If such bands are observed, it would suggest that 
these proteins interact with Ubc9p. Reverse immunoprecipitation will be employed that 
proteins will be purified from tagged and untagged TWI1 or HMBG followed by probing 
with anti-UBC9 antibody. Bands corresponding to Ubc9p are expected. 
In order to analyze whether TWI1 or HMGB are SUMO substrates, tagged TWI1 or 
HMGB will be affinity purified in cell lines expressing or depleted with UBC9. Western 
blots will be probed with anti-SUMO antibody. A slower migration is expected in cell 




The second approach involves the use of in vitro SUMOylation assay. Bacterial strains 
will be engineered to express components of the SUMO pathway – SUMO, E1 
heterodimer of Aos1p/Uba2p and Ubc9p and ATP. The advantage of such an assay is that 
it does not require E3 SUMO ligases. GST-tagged TWI1 or HMGB will be incubated in 
the presence of complete SUMO assay components after which proteins will be resolved 
by SDS-PAGE and then western blotting with anti-GST antibodies. Presence of the 
SUMO-modified form of TWI1 or HMGB will suggest that these are bona fide substrates 
of SUMOp where attachment of SUMOp requires the use of the E2 Ubc9p. We will also 
utilize SUMOplot (http://www.abgent.com/tools/) to identify putative SUMOylation 
sites. These putative sties can be confirmed as actual sites of SUMOp attachment by 
generating Lys mutants that are not SUMO-modified using the SUMOylation assay. 
Affinity purification of nuclear Ubc9p interacting proteins. 
It has been established that SUMOylation regulates various nuclear activities. 
Surprisingly, only a small fraction of the Ubc9p interacting proteins were classified as 
nuclear proteins with possible reason being most nuclear proteins are not released from 
the nucleus. Future effort should be focused on identify additional nuclear Ubc9p 
interacting proteins through protein purification followed by protein mass spectrometry. 
Two nuclei isolation and purification protocols are described previously by Sweet and 
Allis [177,178]. 
Identification and characteristic of SUMO E3 ligases. 
Unlike Ubiquitin E3 ligases, not much is known about SUMO E3 ligases. Identification 
of SUMO E3 ligases will provide insights into the regulation of SUMOylation. We 
initially identify three SUMO E3 ligases candidates (TTHERM_00348490, 
TTHERM_00442270, TTHERM_00227730) based on bioinformatics approach. 
Knockout cell strain and cells expressing GFP-tagged E3#3 were generated. E3#3 
localized to conjugation junction in Tetrahymena, which is interesting now and possibly 
in line with the role of UBC9 in Tetrahymena paring. In order to further characterize this 
being SUMO E3 ligase, global SUMOylation will be analyzed with reduced expression 
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